Ebook Textbook of clinical neuropsychology (2/E): Part 1

594 6 0

Vn Doc 2 Gửi tin nhắn Báo tài liệu vi phạm

Tải lên: 57,242 tài liệu

  • Loading ...
1/594 trang
Tải xuống

Thông tin tài liệu

Ngày đăng: 21/01/2020, 21:26

Part 1 book “Textbook of clinical neuropsychology” has contents: Neuroanatomy for the neuropsychologist, genomics and phenomics, cerebrovascular disease, pediatric cancer, autism spectrum disorder, genetic and neurodevelopmental disorders, hypoxia of the central nervous system,… and other contents. Textbook of Clinical Neuropsychology “Simply superb! Kudos to the Editors for producing a sequel that outshines the original and continues to set the standard for textbooks in clinical neuropsychology in its scope and scholarship Morgan and Ricker have amassed an all-star cast of contributors who present a well curated coverage of the essential aspects of contemporary evidence-based neuropsychological practice with the expertise and depth that will satisfy the ardent graduate student as well as the seasoned academic and clinician Every neuropsychologist should have the Textbook of Clinical Neuropsychology on his or her bookshelf.” – Gordon J Chelune, University of Utah School of Medicine The first edition of the Textbook of Clinical Neuropsychology set a new standard in the field in its scope, breadth, and scholarship This second edition comprises 50 authoritative chapters that will both enlighten and challenge readers from across allied fields of neuroscience, whether novice, mid-level, or senior level professionals It will familiarize the young trainee through to the accomplished professional with fundamentals of the science of neuropsychology and its vast body of research, considering the field’s historical underpinnings, its evolving practice and research methods, the application of science to informed practice, and recent developments and relevant cutting-edge work Its precise commentary recognizes obstacles that remain in our clinical and research endeavors and emphasizes the prolific innovations in interventional techniques that serve the field’s ultimate aim: to better understand brain-behavior relationships and facilitate adaptive functional competence in patients The second edition contains 50 new and completely revised chapters, written by some of the profession’s most recognized and prominent scholar-clinicians, broadening the scope of coverage of the ever-expanding field of neuropsychology and its relationship to related neuroscience and psychological practice domains It is a natural evolution of what has become a comprehensive reference textbook for neuropsychology practitioners Textbook of Clinical Neuropsychology 2nd Edition Edited by Joel E Morgan and Joseph H Ricker Second edition published 2018 by Routledge 711 Third Avenue, New York, NY 10017 and by Routledge Park Square, Milton Park, Abingdon, Oxon, OX14 4RN Routledge is an imprint of the Taylor & Francis Group, an informa business © 2018 Taylor & Francis The right of Joel E Morgan and Joseph H Ricker to be identified as the authors of the editorial material, and of the authors for their individual chapters, has been asserted in accordance with sections 77 and 78 of the Copyright, Designs and Patents Act 1988 All rights reserved No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers Trademark notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe First edition published by Routledge 2008 Library of Congress Cataloging-in-Publication Data Names: Morgan, Joel E., editor | Ricker, Joseph H., editor Title: Textbook of clinical neuropsychology / [edited by] Joel E Morgan, Joseph H Ricker Description: 2nd edition | New York, NY : Routledge, 2018 | Includes bibliographical references and index Identifiers: LCCN 2017034746 | ISBN 9781848726956 (hb : alk paper) | ISBN 9781315271743 (eb) Subjects: MESH: Central Nervous System Diseases—diagnosis | Central Nervous System Diseases—therapy | Neurocognitive Disorders | Neuropsychology—methods Classification: LCC RC346 | NLM WL 301 | DDC 616.8—dc23 LC record available at https://lccn.loc.gov/2017034746 ISBN: 978-1-84872-695-6 (hbk) ISBN: 978-1-315-27174-3 (ebk) Typeset in Times by Apex CoVantage, LLC Dedicated to the memory of Manfred F Greiffenstein, PhD, ABPP (CN, FP), scientist, scholar, clinician, devoted husband and father, and generous friend His wit, intellectual integrity, and fearless pursuit of truth are indelibly etched in our minds and hearts Contents About the editors List of contributors Preface joel e morgan and joseph h ricker Foreword ida sue baron Acknowledgments Part I Foundations of Clinical Neuropsychology Historical Trends in Neuropsychological Assessment william b barr Specialty Training in Clinical Neuropsychology: History and Update on Current Issues linas a bieliauskas and erin mark x xi xiv xv xvii 14 Psychometric Foundations of Neuropsychological Assessment glenn j larrabee 22 Assessment of Neurocognitive Performance Validity kyle brauer boone 39 Differential Diagnosis in Neuropsychology: A Strategic Approach david e hartman 51 Neuroanatomy for the Neuropsychologist christopher m filley and erin d bigler The Central Nervous System and Cognitive Development kathryn c russell Genomics and Phenomics robert m bilder 62 91 102 Functional and Molecular Neuroimaging joseph h ricker and patricia m arenth Part II Disorders in Children and Adults 10 Genetic and Neurodevelopmental Disorders e mark mahone, beth s slomine, and t andrew zabel 11 Traumatic Brain Injury in Children and Adolescents keith owen yeates and brian l brooks 111 125 127 141 12 Pediatric Cancer celiane rey-casserly and brenda j spiegler 158 13 Autism Spectrum Disorder gerry a stefanatos and deborah fein 184 14 Neurodevelopmental Disorders of Attention and Learning: ADHD and LD Across the Life Span jeanette wasserstein, gerry a stefanatos, robert l mapou, yitzchak frank, and josephine elia 15 Consciousness: Disorders, Assessment, and Intervention kathleen t bechtold and megan m hosey 281 332 16 Cerebrovascular Disease c munro cullum, heidi c rossetti, hunt batjer, joanne r festa, kathleen y haaland, and laura h lacritz 350 17 Moderate and Severe Traumatic Brain Injury tresa roebuck-spencer and mark sherer 387 viii Contents 18 Concussion and Mild Traumatic Brain Injury heather g belanger, david f tate, and rodney d vanderploeg 19 Neurocognitive Assessment in Epilepsy: Advances and Challenges joseph i tracy and jennifer r tinker 20 Neurotropic Infections: Herpes Simplex Virus, Human Immunodeficiency Virus, and Lyme Disease richard f kaplan and ronald a cohen 21 Hypoxia of the Central Nervous System ramona o hopkins 22 Parkinson’s Disease and Other Movement Disorders alexander i tröster and robin garrett 23 Cognitive Functions in Adults With Central Nervous System and Non–Central Nervous System Cancers denise d correa and james c root 411 449 32 Clinical Assessment of Posttraumatic Stress Disorder jim andrikopoulos 477 33 Military Service–Related Traumatic Brain Injury louis m french, alison n cernich, and laura l howe 494 34 Pain and Pain-Related Disability kevin w greve, kevin j bianchini, and steven t brewer 507 35 Neuropsychological and Psychological Assessment of Somatic Symptom Disorders greg j lamberty and ivy n miller 560 24 Toxins in the Central Nervous System marc w haut, jennifer wiener hartzell, and maria t moran 587 25 Multiple Sclerosis and Related Disorders peter a arnett, jessica e meyer, victoria c merritt, and lauren b strober 603 26 Neuropsychological Functioning in Autoimmune Disorders elizabeth kozora, andrew burleson, and christopher m filley 31 Complexities of Metabolic Disorders marc a norman, olivia bjorkquist harner, and s joshua kenton 618 Part III Forensic, Ethical, and Practice Issues 36 Forensic Neuropsychology: An Overview of Issues, Admissibility, and Directions jerry j sweet, paul m kaufmann, eric ecklund-johnson, and aaron c malina 37 Basics of Forensic Neuropsychology manfred f greiffenstein and paul m kaufmann 38 Assessment of Incomplete Effort and Malingering in the Neuropsychological Examination scott r millis and paul m kaufmann 742 757 792 823 846 855 857 887 927 27 Sports-Related Concussion william b barr, lindsay d nelson, and michael a mccrea 659 39 Pediatric Forensic Neuropsychology jacobus donders, brian l brooks, elisabeth m s sherman, and michael w kirkwood 942 28 The Three Amnesias russell m bauer and breton asken 678 40 Clinical Neuropsychology in Criminal Forensics robert l denney, rachel l fazio, and manfred f greiffenstein 960 701 41 Disability michael chafetz 980 717 42 Ethical Practice of Clinical Neuropsychology shane s bush 29 Neuropsychological Functioning in Affective and Anxiety-Spectrum Disorders in Adults and Children bernice a marcopulos 30 Dementia glenn smith and alissa butts 1000 Contents ix 43 Evidence-Based Practice in Clinical Neuropsychology jerry j sweet, daniel j goldman, and leslie m guidotti breting 44 Medical and Psychological Iatrogenesis in Neuropsychological Assessment dominic a carone 45 Complementary and Alternative Medicine for Children With Developmental Disabilities karen e wills Part IV Interventions 46 Psychotherapy and the Practice of Clinical Neuropsychology george p prigatano 47 Mindfulness-Based Interventions in Neuropsychology patricia m arenth 1054 1068 1018 48 Collaborative Therapeutic Neuropsychological Assessment tad t gorske 1078 1032 49 Empirically Based Rehabilitation of Neurocognitive Disorder anthony y stringer 1007 50 Clinical Psychopharmacology samuel alperin and lenard a adler 1089 1043 Author index Subject index 1045 1099 1110 Parkinson’s and Other Movement Disorders 545 Cooper, J A., Sagar, H J., & Sullivan, E V (1993) Short-term memory and temporal ordering in early Parkinson’s disease: Effects of disease chronicity and medication Neuropsychologia, 31(9), 933–949 Cordato, N J., Pantelis, C., Halliday, G M., Velakoulis, D., Wood, S J., Stuart, G W.,  .  Morris, J G (2002) Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy Brain, 125(Pt 4), 789–800 Costa, A., Peppe, A., Caltagirone, C., & Carlesimo, G A (2008) Prospective memory impairment in individuals with Parkinson’s disease Neuropsychology, 22(3), 283–292 doi: 2008-05020-001 [pii] 10.1037/0894-4105.22.3.283 Costa, A., Peppe, A., Dell’Agnello, G., Carlesimo, G A., Murri, L., Bonuccelli, U., & Caltagirone, C (2003) Dopaminergic modulation of visual-spatial working memory in Parkinson’s disease Dementia and Geriatric Cognitive Disorders, 15(2), 55–66 Costa, A., Peppe, A., Zabberoni, S., Serafini, F., Barban, F., Scalici, F.,     Carlesimo, G A (2015) Prospective memory performance in individuals with Parkinson’s disease who have mild cognitive impairment Neuropsychology, 29, 782–791 doi: 10.1037/neu0000184 Cousins, R., Hanley, J R., Davies, A D., Turnbull, C J., & Playfer, J R (2000) Understanding memory for faces in Parkinson’s disease: The role of configural processing Neuropsychologia, 38(6), 837–847 Cronin-Golomb, A., Corkin, S., & Growdon, J H (1994) Impaired problem solving in Parkinson’s disease: Impact of a set-shifting deficit Neuropsychologia, 32(5), 579–593 Cummings, J L., Darkins, A., Mendez, M., Hill, M A., & Benson, D F (1988) Alzheimer’s disease and Parkinson’s disease: Comparison of speech and language alterations Neurology, 38(5), 680–684 Czernecki, V., Pillon, B., Houeto, J L., Pochon, J B., Levy, R., & Dubois, B (2002) Motivation, reward, and Parkinson’s disease: Influence of dopatherapy Neuropsychologia, 40, 2257–2267 Dagher, A., Owen, A M., Boecker, H., & Brooks, D J (1999) Mapping the network for planning: A correlational PET activation study with the Tower of London task Brain, 122(Pt 10), 1973–1987 Darvesh, S., & Freedman, M (1996) Subcortical dementia: A neurobehavioral approach Brain and Cognition, 31(2), 230–249 Delis, D C., & Massman, P J (1992) The effects of dopamine fluctuation on cognition and affect In S J Huber & J L Cummings (Eds.), Parkinson’s Disease: Neurobehavioral Aspects (pp 288–302) New York: Oxford University Press den Brok, M G., Dalen, J W., van Gool, W A., Moll van Charante, E P., de Bie, R M., & Richard, E (2015) Apathy in Parkinson’s disease: A systematic review and meta-analysis Movement Disorders, 30, 759–769 doi: 10.1002/mds.26208 Deuschl, G., & Bergman, H (2002) Pathophysiology of nonparkinsonian tremors Movement Disorders, 17(Suppl 3), S41–S48 Devos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P.,  .  Defebvre, L (2008) Comparison of desipramine and citalopram treatments for depression in Parkinson’s disease: A double-blind, randomized, placebo-controlled study Movement Disorders, 23(6), 850–857 doi: 10.1002/mds.21966 Diederich, N J., Pieri, V., & Goetz, C G (2003) Coping strategies for visual hallucinations in Parkinson’s disease Movement Disorders, 18(7), 831–832 doi: 10.1002/mds.10450 Diller, L., Riklan, M., & Cooper, I S (1956) Preoperative response to stress as a criterion of the response to neurosurgery in Parkinson’s disease Journal of the American Geriatrics Society, 4, 1301–1308 Dissanayaka, N N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P A., O’Sullivan, J D.,  .  Mellick, G D (2007) Validity of Hamilton depression inventory in Parkinson’s disease Movement Disorders, 22(3), 399–403 Dobkin, R D., Menza, M., Allen, L A., Gara, M A., Mark, M H., Tiu, J.,  .  Friedman, J (2011) Cognitive-behavioral therapy for depression in Parkinson’s disease: A randomized, controlled trial American Journal of Psychiatry, 168(10), 1066–1074 doi: 10.1176/appi.ajp.2011.10111669 Dobkin, R D., Menza, M., Bienfait, K L., Gara, M., Marin, H., Mark, M H.,  .  Troster, A (2010) The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson’s disease The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), 188–195 doi: 10.1176/appi neuropsych.22.2.188 Dobkin, R D., Troster, A I., Rubino, J T., Allen, L A., Gara, M A., Mark, M H., & Menza, M (2014) Neuropsychological outcomes after psychosocial intervention for depression in Parkinson’s disease The Journal of Neuropsychiatry and Clinical Neurosciences, 26(1), 57–63 doi: 10.1176/appi.neuropsych 12120381 Dorsey, E R., Constantinescu, R., Thompson, J P., Biglan, K M., Holloway, R G., Kieburtz, K.,  .  Tanner, C M (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 Neurology, 68(5), 384–386 doi: 10.1212/01.wnl.0000247740.47667.03 Downes, J J., Priestley, N M., Doran, M., Ferran, J., Ghadiali, E., & Cooper, P (1998) Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson’s disease Behavioural Neurology, 11(3), 173–183 Dubois, B., Deweer, B., & Pillon, B (1996) The cognitive syndrome of progressive supranuclear palsy Advances in Neurology, 69, 399–403 Dubois, B., Pillon, B., Legault, F., Agid, Y., & Lhermitte, F (1988) Slowing of cognitive processing in progressive supranuclear palsy: A comparison with Parkinson’s disease Archives of Neurology, 45(11), 1194–1199 Duff, K., Beglinger, L J., Theriault, D., Allison, J., & Paulsen, J S (2010) Cognitive deficits in Huntington’s disease on the repeatable battery for the assessment of neuropsychological status Journal of Clinical and Experimental Neuropsychology, 32(3), 231–238 doi: 10.1080/13803390902926184 Dujardin, K., Defebvre, L., Krystkowiak, P., Degreef, J F., & Destee, A (2003) Executive function differences in multiple system atrophy and Parkinson’s disease Parkinsonism and Related Disorders, 9, 205–211 Dymek, M P., Atchison, P., Harrell, L., & Marson, D C (2001) Competency to consent to medical treatment in cognitively impaired patients with Parkinson’s disease Neurology, 56(1), 17–24 Elgh, E., Domellof, M., Linder, J., Edstrom, M., Stenlund, H., & Forsgren, L (2009) Cognitive function in early Parkinson’s disease: A population-based study European Journal of Neurology, 16(12), 1278–1284 doi: ENE2707 [pii] 10.1111/j.1468-1331 2009.02707.x Ellfolk, U., Huurinainen, S., Joutsa, J., & Karrasch, M (2012) The effect of encoding condition on free recall in Parkinson’s disease: 546 Alexander I Tröster and Robin Garrett Incidental and intentional memory are equally affected The Clinical Neuropsychologist , 26 (6), 909–925 doi: 10.1080/13854046.2012.697192 Ephraty, L., Porat, O., Israeli, D., Cohen, O S., Tunkel, O., Yael, S.,  .  Hassin-Baer, S (2007) Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations Movement Disorders, 22(4), 566–569 doi: 10.1002/mds.21319 Estanga, A., Rodriguez-Oroz, M C., Ruiz-Martinez, J., Barandiaran, M., Gorostidi, A., Bergareche, A.,  .  Marti-Masso, J F (2014) Cognitive dysfunction in Parkinson’s disease related to the R1441G mutation in LRRK2 Parkinsonism Relat Disord, 20(10), 1097–1100 doi: 10.1016/j.parkreldis.2014.07.005 Evans, A H., & Lees, A J (2004) Dopamine dysregulation syndrome in Parkinson’s disease Current Opinion in Neurology, 17(4), 393–398 Faglioni, P., Saetti, M C., & Botti, C (2000) Verbal learning strategies in Parkinson’s disease Neuropsychology, 14(3), 456–470 Fama, R., Sullivan, E V., Shear, P K., Stein, M., Yesavage, J A., Tinklenberg, J R., & Pfefferbaum, A (2000) Extent, pattern, and correlates of remote memory impairment in Alzheimer’s disease and Parkinson’s disease Neuropsychology, 14(2), 265–276 Farrer, M., Gwinn-Hardy, K., Muenter, M., DeVrieze, F W., Crook, R., Perez-Tur, J.,  .  Hardy, J (1999) A chromosome 4p haplotype segregating with Parkinson’s disease and postural tremor Human Molecular Genetics, 8(1), 81–85 Faust-Socher, A., Kenett, Y N., Cohen, O S., Hassin-Baer, S., & Inzelberg, R (2014) Enhanced creative thinking under dopaminergic therapy in Parkinson disease Annals of Neurology, 75(6), 935–942 doi: 10.1002/ana.24181 Feigin, A., Ghilardi, M F., Carbon, M., Edwards, C., Fukuda, M., Dhawan, V.,  .  Eidelberg, D (2003) Effects of levodopa on motor sequence learning in Parkinson’s disease Neurology, 60, 1744–1749 Feinstein, A., Stergiopoulos, V., Fine, J., & Lang, A E (2001) Psychiatric outcome in patients with a psychogenic movement disorder: A prospective study Neuropsychiatry Neuropsychology and Behavioral Neurology, 14(3), 169–176 Fenelon, G., & Alves, G (2010) Epidemiology of psychosis in Parkinson’s disease Journal of the Neurological Sciences, 289(1–2), 12–17 doi: 10.1016/j.jns.2009.08.014 Ferman, T J., Smith, G E., Boeve, B F., Graff-Radford, N R., Lucas, J A., Knopman, D S.,  .  Dickson, D W (2006) Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer’s disease The Clinical Neuropsychologist, 20(4), 623–636 Fernandez, H H., Aarsland, D., Fenelon, G., Friedman, J H., Marsh, L., Troster, A I.,  .  Goetz, C G (2008) Scales to assess psychosis in Parkinson’s disease: Critique and recommendations Movement Disorders, 23(4), 484–500 doi: 10.1002/mds.21875 Fernandez, H H., See, R H., Gary, M F., Bowers, D., Rodriguez, R L., Jacobson, C T., & Okun, M S (2009) Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance Journal of Geriatric Psychiatry and Neurology, 22(4), 223–227 doi: 10.1177/0891988709335792 Fetoni, V., Soliveri, P., Monza, D., Testa, D., & Girotti, F (1999) Affective symptoms in multiple system atrophy and Parkinson’s disease: Response to levodopa therapy Journal of Neurology, Neurosurgery, and Psychiatry, 66(4), 541–544 Fields, J A (2015) Effects of deep brain stimulation in movement disorders on cognition and behavior In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp. 332–375) New York: Oxford University Press Fields, J A., Tröster, A I., Woods, S P., Higginson, C I., Wilkinson, S B., Lyons, K E.,  .  Pahwa, R (2003) Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor Journal of Neurology, Neurosurgery, and Psychiatry, 74(3), 305–311 Filoteo, J V., Friedrich, F J., Rilling, L M., Davis, J D., Stricker, J L., & Prenovitz, M (2003) Semantic and cross-case identity priming in patients with Parkinson’s disease Journal of Clinical and Experimental Neuropsychology, 25(4), 441–456 Filoteo, J V., Rilling, L M., Cole, B., Williams, B J., Davis, J D., & Roberts, J W (1997) Variable memory profiles in Parkinson’s disease Journal of Clinical and Experimental Neuropsychology, 19(6), 878–888 Filoteo, J V., Salmon, D P., Schiehser, D M., Kane, A E., Hamilton, J M., Rilling, L M.,     Galasko, D R (2009) Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson’s disease with dementia Journal of Clinical and Experimental Neuropsychology, 31(7), 823–834 doi: 908749749 [pii] 10.1080/13803390802572401 Filoteo, J V., Williams, B J., Rilling, L M., & Roberts, J W (1997) Performance of Parkinson’s disease patients on the visual search and attention test: Impairment in single-feature but not dualfeature visual search Archives of Clinical Neuropsychology, 12(7), 621–634 Finali, G., Piccirilli, M., & Piccinin, G L (1994) Neuropsychological correlates of L-deprenyl therapy in idiopathic parkinsonism Progress in Neuro-Psychopharmacology and Biological Psychiatry, 18(1), 115–128 Fink, K D., Crane, A T., Leveque, X., Dues, D J., Huffman, L D., Moore, A C.,  .  Dunbar, G L (2014) Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington’s disease Stem Cells Translational Medicine, 3(5), 620–631 doi: 10.5966/sctm.2013-0151 Finton, M J., Lucas, J A., Graff-Radford, N R., & Uitti, R J (1998) Analysis of visuospatial errors in patients with Alzheimer’s disease or Parkinson’s disease Journal of Clinical and Experimental Neuropsychology, 20, 186–193 Foerde, K., & Shohamy, D (2011) The role of the basal ganglia in learning and memory: Insight from Parkinson’s disease Neurobiology of Learning and Memory, 96(4), 624–636 doi: 10.1016/j nlm.2011.08.006 Foltynie, T., Brayne, C E., Robbins, T W., & Barker, R A (2004) The cognitive ability of an incident cohort of Parkinson’s patients in the UK: The CamPaIGN study Brain, 127(Pt 3), 550–560 Foltynie, T., Goldberg, T E., Lewis, S G., Blackwell, A D., Kolachana, B S., Weinberger, D R.,  .  Barker, R A (2004) Planning ability in Parkinson’s disease is influenced by the COMT val158met polymorphism Movement Disorders, 19(8), 885–891 Forjaz, M J., Ayala, A., Martinez-Martin, P., Dujardin, K., Pontone, G M., Starkstein, S E.,  .  Leentjens, A F (2015) Is the Parkinson anxiety scale comparable across raters? Movement Disorders, 30(4), 545–551 doi: 10.1002/mds.26111 Parkinson’s and Other Movement Disorders 547 Fournet, N., Moreaud, O., Roulin, J L., Naegele, B., & Pellat, J (2000) Working memory functioning in medicated Parkinson’s disease patients and the effect of withdrawal of dopaminergic medication Neuropsychology, 14(2), 247–253 Freedman, M., Rivoira, P., Butters, N., Sax, D S., & Feldman, R G (1984) Retrograde amnesia in Parkinson’s disease Canadian Journal of Neurological Sciences, 11(2), 297–301 Freeman, R Q., Giovannetti, T., Lamar, M., Cloud, B S., Stern, R A., Kaplan, E., & Libon, D J (2000) Visuoconstructional problems in dementia: Contribution of executive systems functions Neuropsychology, 14(3), 415–426 Friedman, J H., Alves, G., Hagell, P., Marinus, J., Marsh, L., Martinez-Martin, P.,  .  Schrag, A (2010) Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson’s disease Movement Disorders: Official Journal of the Movement Disorder Society, 25(7), 805–822 doi: 10.1002/mds.22989 Fünfgeld, E W (1967) Psychopathologie und Klinik des Parkinsonismus vor und nach Stereotaktischen Operationen Berlin: Springer Verlag Gabrieli, J.D.E., Singh, J., Stebbins, G., & Goetz, C G (1996) Reduced working memory span in Parkinson’s disease: Evidence for the role of a frontostriatal system in working and strategic memory Neuropsychology, 10, 322–332 Galasko, D., Katzman, R., Salmon, D P., & Hansen, L (1996) Clinical and neuropathological findings in Lewy body dementias Brain and Cognition, 31(2), 166–175 Gao, L., Diaz-Corrales, F J., Carrillo, F., Diaz-Martin, J., CaceresRedondo, M T., Carballo, M.,  .  Mir, P (2010) Brain-derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease Acta Neurologica Scandinavica, 122(1), 41–45 doi: 10.1111/j.1600-0404.2009.01253.x Gasparini, M., Bonifati, V., Fabrizio, E., Fabbrini, G., Brusa, L., Lenzi, G L., & Meco, G (2001) Frontal lobe dysfunction in essential tremor: A preliminary study Journal of Neurology, 248(5), 399–402 Gasparini, M., Fabrizio, E., Bonifati, V., & Meco, G (1997) Cognitive improvement during Tolcapone treatment in Parkinson’s disease Journal of Neural Transmission, 104(8–9), 887–894 Gerstenecker, A., Duff, K., Mast, B., Litvan, I., & Group, E.-P S (2013) Behavioral abnormalities in progressive supranuclear palsy Psychiatry Research, 210(3), 1205–1210 doi: 10.1016/j psychres.2013.08.045 Gerstenecker, A., Mast, B., Duff, K., Ferman, T J., Litvan, I., & Group, E.-P S (2013) Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy Archives of Clinical Neuropsychology, 28(2), 104–113 doi: 10.1093/arclin/ acs098 Gilman, S., Wenning, G K., Low, P A., Brooks, D J., Mathias, C J., Trojanowski, J Q.,  .  Vidailhet, M (2008) Second consensus statement on the diagnosis of multiple system atrophy Neurology, 71(9), 670–676 doi: 10.1212/01.wnl.0000324625.00404.15 Giovannoni, G., O’Sullivan, J D., Turner, K., Manson, A J., & Lees, A J (2000a) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies Journal of Neurology, Neurosurgery, and Psychiatry, 68(4), 423–428 Giovannoni, G., O’Sullivan, J D., Turner, K., Manson, A J., & Lees, A J (2000b) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies Journal of Neurology, Neurosurgery, and Psychiatry, 68(4), 423–428 Globus, M., Mildworf, B., & Melamed, E (1985) Cerebral blood flow and cognitive impairment in Parkinson’s disease Neurology, 35(8), 1135–1139 Gnanalingham, K K., Byrne, E J., Thornton, A., Sambrook, M A., & Bannister, P (1997) Motor and cognitive function in Lewy body dementia: Comparison with Alzheimer’s and Parkinson’s diseases Journal of Neurology, Neurosurgery, and Psychiatry, 62(3), 243–252 Goetz, C G (1992) The historical background of behavioral studies in Parkinson’s disease In S J Huber & J L Cummings (Eds.), Parkinson’s Disease: Neurobehavioral Aspects (pp.  3–9) New York: Oxford University Press Goetz, C G., Stebbins, G T., & Ouyang, B (2011) Visual plus nonvisual hallucinations in Parkinson’s disease: Development and evolution over 10 years Movement Disorders, 26(12), 2196– 2200 doi: 10.1002/mds.23835 Golbe, L I., Davis, P H., Schoenberg, B S., & Duvoisin, R C (1988) Prevalence and natural history of progressive supranuclear palsy Neurology, 38(7), 1031–1034 Golbe, L I., Di Iorio, G., Sanges, G., Lazzarini, A M., La Sala, S., Bonavita, V., & Duvoisin, R C (1996) Clinical genetic analysis of Parkinson’s disease in the Contursi kindred Annals of Neurology, 40(5), 767–775 Goldman, J G., Holden, S., Bernard, B., Ouyang, B., Goetz, C G., & Stebbins, G T (2013) Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson’s disease Movement Disorders, 28(14), 1972–1979 doi: 10.1002/mds 25655 Goldman, J G., Williams-Gray, C., Barker, R A., Duda, J E., & Galvin, J E (2014) The spectrum of cognitive impairment in Lewy body diseases Movement Disorders, 29(5), 608–621 doi: 10.1002/mds.25866 Gomperts, S N., Locascio, J J., Marquie, M., Santarlasci, A L., Rentz, D M., Maye, J.,  .  Growdon, J H (2012) Brain amyloid and cognition in Lewy body diseases Movement Disorders, 27(8), 965–973 doi: 10.1002/mds.25048 Goris, A., Williams-Gray, C H., Clark, G R., Foltynie, T., Lewis, S J., Brown, J.,  .  Sawcer, S J (2007) Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson’s disease Annals of Neurology, 62(2), 145–153 doi: 10.1002/ana.21192 Grafman, J., Litvan, I., & Stark, M (1995) Neuropsychological features of progressive supranuclear palsy Brain and Cognition, 28(3), 311–320 Graham, N L., Bak, T H., & Hodges, J R (2003) Corticobasal degeneration as a cognitive disorder Movement Disorders, 18(11), 1224–1232 Graham, N L., Bak, T H., Patterson, K., & Hodges, J R (2003) Language function and dysfunction in corticobasal degeneration Neurology, 61(4), 493–499 Gratwicke, J., Jahanshahi, M., & Foltynie, T (2015) Parkinson’s disease dementia: A neural networks perspective Brain, 138, 1454–1476 doi: 10.1093/brain/awv104 Grimes, D A., Lang, A E., & Bergeron, C B (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration Neurology, 53(9), 1969–1974 548 Alexander I Tröster and Robin Garrett Grossman, M., Carvell, S., Stern, M B., Gollomp, S., & Hurtig, H I (1992) Sentence comprehension in Parkinson’s disease: The role of attention and memory Brain and Language, 42(4), 347–384 Grossman, M., Zurif, E., Lee, C., Prather, P., Kalmanson, J., Stern, M B., & Hurtig, H I (2002) Information processing speed and sentence comprehension in Parkinson’s disease Neuropsychology, 16(2), 174–181 Gschwandtner, U., Aston, J., Renaud, S., & Fuhr, P (2001) Pathologic gambling in patients with Parkinson’s disease Clinical Neuropharmacology, 24(3), 170–172 Gupta, A., & Lang, A E (2009) Psychogenic movement disorders Current Opinion in Neurology, 22(4), 430–436 doi: 10.1097/ WCO.0b013e32832dc169 Halliday, G M., Leverenz, J B., Schneider, J S., & Adler, C H (2014) The neurobiological basis of cognitive impairment in Parkinson’s disease Movement Disorders, 29(5), 634–650 doi: 10.1002/mds.25857 Halliday, G M., & McCann, H (2010) The progression of pathology in Parkinson’s disease Annals of the New York Academy of Sciences , 1184 , 188–195 doi: NYAS5118 [pii] 10.1111/j.1749-6632.2009.05118.x Hamilton, J M., Salmon, D P., Galasko, D., Delis, D C., Hansen, L A., Masliah, E.,  .  Thal, L J (2004) A comparison of episodic memory deficits in neuropathologically confirmed Dementia with Lewy bodies and Alzheimer’s disease Journal of the International Neuropsychological Society, 10(5), 689–697 Hamilton, M (1960) A rating scale for depression Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62 Hawkins, K., Jennings, D., Marek, K., Siderowf, A., Stern, M., & PARS Study Investigators (2010) Cognitive deficits associated with dopamine transporter loss in the pre-motor subjects in the PARS cohort Movement Disorders, 25(Suppl 3), S690–S691 Haynes, W I., & Haber, S N (2013) The organization of prefrontalsubthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: Implications for Basal Ganglia models and deep brain stimulation Journal of Neuroscience, 33(11), 4804–4814 doi: 10.1523/JNEUROSCI.4674-12.2013 Healy, D G., Abou-Sleiman, P M., Gibson, J M., Ross, O A., Jain, S., Gandhi, S.,  .  Lynch, T (2004) PINK1 (PARK6) associated Parkinson disease in Ireland Neurology , 63 (8), 1486–1488 Healy, D G., Falchi, M., O’Sullivan, S S., Bonifati, V., Durr, A., Bressman, S.,  .  International, L C (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: A case-control study Lancet Neurology, 7(7), 583–590 doi: 10.1016/S1474-4422(08)70117-0 Heaton, R K., Chelune, G J., Talley, J L., Kay, G G., & Curtiss, G (1993) Wisconsin Card Sorting Test Manual Odessa: Psychological Assessment Resources Heiss, C., Kalbe, E., & Kessler, J (2001) Quantitative und qualitative Analysen von verbalen Flüssigkeitsaufgaben bei Parkinsonpatienten Zeitschrift für Neuropsychologie, 12(3), 188–199 Henry, J D., & Crawford, J R (2004) Verbal fluency deficits in Parkinson’s disease: A meta-analysis Journal of the International Neuropsychological Society, 10(4), 608–622 Herrera, E., Cuetos, F., & Ribacoba, R (2012) Verbal fluency in Parkinson’s disease patients on/off dopamine medication Neuropsychologia , 50 (14), 3636–3640 doi: 10.1016/j neuropsychologia.2012.09.016 Hietanen, M H (1991) Selegiline and cognitive function in Parkinson’s disease Acta Neurologica Scandanavica, 84(5), 407–410 Higginson, C I., Fields, J A., Koller, W C., & Tröster, A I (2001) Questionnaire assessment potentially overestimates anxiety in Parkinson’s disease Journal of Clinical Psychology in Medical Settings, 8(2), 95–99 Higginson, C I., Wheelock, V L., Levine, D., Pappas, C T., & Sigvardt, K A (2011) Predictors of HVOT performance in Parkinson’s disease Applied Neuropsychology, 18(3), 210–215 doi: 10.1080/09084282.2011.595447 Hilker, R., Thomas, A V., Klein, J C., Weisenbach, S., Kalbe, E., Burghaus, L.,  .  Heiss, W D (2005) Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways Neurology, 65(11), 1716–1722 doi: 65/11/1716 [pii] 10.1212/01.wnl.0000191154.78131.f6 Hindle, J V., Petrelli, A., Clare, L., & Kalbe, E (2013) Nonpharmacological enhancement of cognitive function in Parkinson’s disease: A systematic review Movement Disorders, 28(8), 1034– 1049 doi: 10.1002/mds.25377 Hinnell, C., Hurt, C S., Landau, S., Brown, R G., Samuel, M., & Group, P.-P S (2012) Nonmotor versus motor symptoms: How much they matter to health status in Parkinson’s disease? Movement Disorders, 27(2), 236–241 doi: 10.1002/mds.23961 Hinson, V K., Weinstein, S., Bernard, B., Leurgans, S E., & Goetz, C G (2006) Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders Parkinsonism and Related Disorders, 12(3), 177–180 doi: 10.1016/j.parkreldis.2005.10.006 Hirtz, D., Thurman, D J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A R., & Zalutsky, R (2007) How common are the “common” neurologic disorders? Neurology, 68(5), 326–337 doi: 10.1212/01.wnl.0000252807.38124.a3 Hogl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B.,  .  Goetz, C G (2010) Scales to assess sleep impairment in Parkinson’s disease: Critique and recommendations Movement Disorders, 25(16), 2704–2716 doi: 10.1002/mds.23190 Hohler, A D., Ransom, B R., Chun, M R., Tröster, A I., & Samii, A (2003) The youngest reported case of corticobasal degeneration Parkinsonism and Related Disorders, 10, 47–50 Holdorff, B (2002) Friedrich Heinrich Lewy (1885–1950) and his work Journal of the History of the Neurosciences, 11(1), 19–28 Homann, C N., Suppan, K., Homann, B., Crevenna, R., Ivanic, G., & Ruzicka, E (2003) Driving in Parkinson’s disease—a health hazard? Journal of Neurology, 250(12), 1439–1446 Hoogland, J., de Bie, R M., Williams-Gray, C H., Muslimovic, D., Schmand, B., & Post, B (2010) Catechol-O-methyltransferase val158met and cognitive function in Parkinson’s disease Movement Disorders, 25(15), 2550–2554 doi: 10.1002/mds.23319 Huang, X., Chen, P., Kaufer, D I., Troster, A I., & Poole, C (2006) Apolipoprotein E and dementia in Parkinson disease: A metaanalysis Archives of Neurology, 63(2), 189–193 Huber, S J., Shuttleworth, E C., & Paulson, G W (1986) Dementia in Parkinson’s disease Archives of Neurology, 43(10), 987–990 Huber, S J., Shuttleworth, E C., Paulson, G W., Bellchambers, M J., & Clapp, L E (1986) Cortical vs subcortical dementia: Neuropsychological differences Archives of Neurology, 43(4), 392–394 Hugdahl, K., & Wester, K (2000) Neurocognitive correlates of stereotactic thalamotomy and thalamic stimulation in Parkinsonian patients Brain and Cognition, 42(2), 231–252 Parkinson’s and Other Movement Disorders 549 Huntington, G (1872) On chorea Advances in Neurology, 1, 33–35 Hurtig, H I., Trojanowski, J Q., Galvin, J., Ewbank, D., Schmidt, M L., Lee, V M.-Y.,  .  Arnold, S E (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease Neurology, 54(10), 1916–1921 Irwin, D J., White, M T., Toledo, J B., Xie, S X., Robinson, J L., Van Deerlin, V.,  .  Trojanowski, J Q (2012) Neuropathologic substrates of Parkinson disease dementia Annals of Neurology, 72(4), 587–598 doi: 10.1002/ana.23659 Ito, K., Nagano-Saito, A., Kato, T., Arahata, Y., Nakamura, A., Kawasumi, Y.,  .  Brooks, D J (2002) Striatal and extrastriatal dysfunction in Parkinson’s disease with dementia: A 6-[18F]fluoro-L-dopa PET study Brain, 125(Pt 6), 1358–1365 Jahanshahi, M., Czernecki, V., & Zurowski, A M (2011) Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia Movement Disorders, 26(Suppl 1), S63–S78 doi: 10.1002/mds.23511 Jahanshahi, M., Rowe, J., & Fuller, R (2003) Cognitive executive function in dystonia Movement Disorders, 18(12), 1470–1481 Janicki, S C., Cosentino, S., & Louis, E D (2013) The cognitive side of essential tremor: What are the therapeutic implications? Therapeutic Advances in Neurological Disorders, 6(6), 353–368 doi: 10.1177/1756285613489591 Jellinger, K A (2014) Neuropathology of multiple system atrophy: New thoughts about pathogenesis Movement Disorders, 29(14), 1720–1741 doi: 10.1002/mds.26052 Jellinger, K A., & Attems, J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease Acta Neuropathologica , 115 (4), 427–436 doi: 10.1007/ s00401-008-0347-5 Jordbru, A A., Smedstad, L M., Klungsoyr, O., & Martinsen, E W (2014) Psychogenic gait disorder: A randomized controlled trial of physical rehabilitation with one-year follow-up Journal of Rehabilitation Medicine, 46(2), 181–187 doi: 10.2340/16501977-1246 Jurko, M F., & Andy, O J (1964) Psychological aspects of diencephalotomy Journal of Neurology, Neurosurgery, and Psychiatry, 27, 516–521 Karadi, K., Lucza, T., Aschermann, Z., Komoly, S., Deli, G., Bosnyak, E.,  .  Kovacs, N (2015) Visuospatial impairment in Parkinson’s disease: The role of laterality Laterality, 20(1), 112–127 doi: 10.1080/1357650X.2014.936444 Katai, S., Maruyama, T., Hashimoto, T., & Ikeda, S (2003) Event based and time based prospective memory in Parkinson’s disease Journal of Neurology, Neurosurgery, and Psychiatry, 74(6), 704–709 Kaufer, D I (2002) Pharmacologic therapy of dementia with Lewy bodies Journal of Geriatric Psychiatry and Neurology, 15(4), 224–232 Kehagia, A A., Barker, R A., & Robbins, T W (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease Lancet Neurology, 9(12), 1200–1213 doi: 10.1016/S1474-4422(10)70212-X Kensinger, E A., Shearer, D K., Locascio, J J., & Growdon, J H (2003) Working memory in mild Alzheimer’s disease and early Parkinson’s disease Neuropsychology, 17(2), 230–239 Kertesz, A (2003) Pick complex: An integrative approach to frontotemporal dementia: Primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy Neurologist, 9(6), 311–317 Kertesz, A., Martinez-Lage, P., Davidson, W., & Munoz, D G (2000) The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia Neurology, 55(9), 1368–1375 Kieburtz, K., McDermott, M., Como, P., Growdon, J., Brady, J., Carter, J.,  .  Group, T.P.S (1994) The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson’s disease Neurology, 44(9), 1756–1759 Killoran, A., & Biglan, K M (2014) Current therapeutic options for Huntington’s disease: Good clinical practice versus evidencebased approaches? Movement Disorders, 29(11), 1404–1413 doi: 10.1002/mds.26014 Klein, J C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S.,  .  Hilker, R (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo Neurology, 74(11), 885–892 doi: WNL.0b013e3181d55f61 [pii] 10.1212/WNL.0b013e3181d55f61 Kliegel, M., Altgassen, M., Hering, A., & Rose, N S (2011) A process-model based approach to prospective memory impairment in Parkinson’s disease Neuropsychologia, 49(8), 2166–2177 doi: 10.1016/j.neuropsychologia.2011.01.024 Knoke, D., Taylor, A E., & Saint-Cyr, J A (1998) The differential effects of cueing on recall in Parkinson’s disease and normal subjects Brain and Cognition, 38(2), 261–274 Koller, W C (1984) Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy Cortex, 20(2), 307–311 Koller, W C., Marjama, J., & Tröster, A I (2002) Psychogenic movement disorders In J Jankovic & E Tolosa (Eds.), Parkinson’s Disease and Movement Disorders (4th ed., pp.  546–552) Philadelphia, PA: Lippincott, Williams & Wilkins Kranick, S., Ekanayake, V., Martinez, V., Ameli, R., Hallett, M., & Voon, V (2011) Psychopathology and psychogenic movement disorders Movement Disorders, 26(10), 1844–1850 doi: 10.1002/ mds.23830 Kudlicka, A., Clare, L., & Hindle, J V (2011) Executive functions in Parkinson’s disease: Systematic review and meta-analysis Movement Disorders, 26(13), 2305–2315 doi: 10.1002/mds.23868 Kulisevsky, J., Garcia-Sanchez, C., Berthier, M L., Barbanoj, M., Pascual-Sedano, B., Gironell, A., & Estevez-Gonzalez, A (2000) Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two-year follow-up study of previously untreated patients Movement Disorders, 15, 613–626 Kurz, M W., Dekomien, G., Nilsen, O B., Larsen, J P., Aarsland, D., & Alves, G (2009) APOE alleles in Parkinson disease and their relationship to cognitive decline: A population-based, longitudinal study Journal of Geriatric Psychiatry and Neurology, 22(3), 166–170 doi: 10.1177/0891988709332945 Kuzis, G., Sabe, L., Tiberti, C., Merello, M., Leiguarda, R., & Starkstein, S E (1999) Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 12(4), 265–269 Lacritz, L H., Dewey, R., Jr., Giller, C., & Cullum, C M (2002) Cognitive functioning in individuals with “benign” essential tremor Journal of the International Neuropsychological Society, 8(1), 125–129 Lang, A E (2003) Corticobasal degeneration: Selected developments Movement Disorders, 18(Suppl 6), S51–S56 Lang, A E (2011) Phenomenology of psychogenic movement disorders In M Hallett, A E Lang, J Jankovic, S Fahn, P W 550 Alexander I Tröster and Robin Garrett Halligan, V Voon, & C R Cloninger (Eds.), Psychogenic Movement Disorders and Other Conversion Disorders (pp 6–13) Cambridge, UK: Cambridge University Press Lange, K W., Robbins, T W., Marsden, C D., James, M., Owen, A M., & Paul, G M (1992) L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction Psychopharmacology, 107(2–3), 394–404 Lange, K W., Tucha, O., Alders, G L., Preier, M., Csoti, I., Merz, B.,  .  Naumann, M (2003) Differentiation of parkinsonian syndromes according to differences in executive functions Journal of Neural Transmission, 110(9), 983–995 Langenbahn, D M., Ashman, T., Cantor, J., & Trott, C (2013) An evidence-based review of cognitive rehabilitation in medical conditions affecting cognitive function Archives of Physical Medicine and Rehabilitation , 94 (2), 271–286 doi: 10.1016/j apmr.2012.09.011 Lauterbach, E C., & Duvoisin, R C (1991) Anxiety disorders in familial parkinsonism American Journal of Psychiatry, 148(2), 274 Lawrence, A D., Evans, A H., & Lees, A J (2003) Compulsive use of dopamine replacement therapy in Parkinson’s disease: Reward systems gone awry? Lancet Neurology, 2, 595–604 Lee, A C., Harris, J P., & Calvert, J E (1998) Impairments of mental rotation in Parkinson’s disease Neuropsychologia, 36(1), 109–114 Lee, C., Grossman, M., Morris, J., Stern, M B., & Hurtig, H I (2003) Attentional resource and processing speed limitations during sentence processing in Parkinson’s disease Brain and Language, 85(3), 347–356 Lee, S S., Wild, K., Hollnagel, C., & Grafman, J (1999) Selective visual attention in patients with frontal lobe lesions or Parkinson’s disease Neuropsychologia, 37(5), 595–604 Lee, W., Williams, D R., & Storey, E (2012) Cognitive testing in the diagnosis of parkinsonian disorders: A critical appraisal of the literature Movement Disorders, 27(10), 1243–1254 doi: 10.1002/mds.25113 Lee, Y E., Williams, D R., & Anderson, J F (2016) Frontal deficits differentiate progressive supranuclear palsy from Parkinson’s disease Journal of Neuropsychology, 10, 1–14 doi: 10.1111/ jnp.12053 Leentjens, A F., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I H., Starkstein, S E.,  .  Goetz, C G (2008a) Anxiety rating scales in Parkinson’s disease: Critique and recommendations Movement Disorders, 23(14), 2015–2025 doi: 10.1002/ mds.22233 Leentjens, A F., Dujardin, K., Marsh, L., Martinez-Martin, P., Richard, I H., Starkstein, S E.,  .  Goetz, C G (2008b) Apathy and anhedonia rating scales in Parkinson’s disease: Critique and recommendations Movement Disorders, 23(14), 2004–2014 doi: 10.1002/mds.22229 Leentjens, A F., Dujardin, K., Pontone, G M., Starkstein, S E., Weintraub, D., & Martinez-Martin, P (2014) The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale Movement Disorders, 29(8), 1035–1043 doi: 10.1002/ mds.25919 Leentjens, A F., Verhey, F R., Lousberg, R., Spitsbergen, H., & Wilmink, F W (2000) The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson’s disease International Journal of Geriatric Psychiatry, 15(7), 644–649 Leentjens, A F., Verhey, F R., Luijckx, G J., & Troost, J (2000) The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson’s disease Movement Disorders, 15(6), 1221–1224 Lees, A J., & Smith, E (1983) Cognitive deficits in the early stages of Parkinson’s disease Brain, 106(Pt 2), 257–270 Leiguarda, R., Lees, A J., Merello, M., Starkstein, S., & Marsden, C D (1994) The nature of apraxia in corticobasal degeneration Journal of Neurology, Neurosurgery, and Psychiatry, 57(4), 455–459 Leplow, B., Dierks, C., Herrmann, P., Pieper, N., Annecke, R., & Ulm, G (1997) Remote memory in Parkinson’s disease and senile dementia Neuropsychologia, 35(4), 547–557 Lesage, S., Durr, A., Tazir, M., Lohmann, E., Leutenegger, A L., Janin, S.,     French Parkinson’s Disease Genetics Study, G (2006) LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs New England Journal of Medicine, 354(4), 422–423 doi: 10.1056/NEJMc055540 Leverenz, J B., Watson, G S., Shofer, J., Zabetian, C P., Zhang, J., & Montine, T J (2011) Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease Parkinsonism and Related Disorders, 17(1), 61–64 doi: 10.1016/j.parkreldis.2010.10.003 Levin, B E., & Katzen, H L (1995) Early cognitive changes and nondementing behavioral abnormalities in Parkinson’s disease In W J Weiner & A E Lang (Eds.), Advances in Neurology: Vol 65 Behavioral Neurology of Movement Disorders (pp.  85–95) New York: Raven Press Levin, B E., Llabre, M M., Reisman, S., Weiner, W J., SanchezRamos, J., Singer, C., & Brown, M C (1991) Visuospatial impairment in Parkinson’s disease Neurology, 41(3), 365–369 Levin, B E., Llabre, M M., & Weiner, W J (1989) Cognitive impairments associated with early Parkinson’s disease Neurology, 39(4), 557–561 Lewis, F M., Lapointe, L L., & Murdoch, B E (1998) Language impairment in Parkinson’s disease Aphasiology, 12, 193–206 Lewis, S J., Cools, R., Robbins, T W., Dove, A., Barker, R A., & Owen, A M (2003) Using executive heterogeneity to explore the nature of working memory deficits in Parkinson’s disease Neuropsychologia, 41(6), 645–654 LeWitt, P A., Rezai, A R., Leehey, M A., Ojemann, S G., Flaherty, A W., Eskandar, E N.,  .  Feigin, A (2011) AAV2-GAD gene therapy for advanced Parkinson’s disease: A double-blind, sham-surgery controlled, randomised trial Lancet Neurology, 10(4), 309–319 doi: 10.1016/S1474-4422(11)70039-4 Lewy, F H (1912) Paralysis agitans I: Pathologische anatomie In M Lewandowsky (Ed.), Handbuch Der Neurologie, Band (pp. 920–933) Berlin: Springer Verlag Lewy, F H (1923) Die Lehre vom Tonus und der Bewegung Zugleich Systmatische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der Paralysis Agitans Berlin: Julius Springer Litvan, I., Agid, Y., Goetz, C., Jankovic, J., Wenning, G K., Brandel, J P.,  .  Bartko, J J (1997) Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study Neurology, 48(1), 119–125 Litvan, I., Cummings, J L., & Mega, M (1998) Neuropsychiatric features of corticobasal degeneration Journal of Neurology, Neurosurgery, and Psychiatry, 65(5), 717–721 Litvan, I., Goldman, J G., Troster, A I., Schmand, B A., Weintraub, D., Petersen, R C.,     Emre, M (2012) Diagnostic Parkinson’s and Other Movement Disorders 551 criteria for mild cognitive impairment in Parkinson’s disease: Movement disorder society task force guidelines Movement Disorders, 27(3), 349–356 doi: 10.1002/mds.24893 Litvan, I., Grafman, J., Gomez, C., & Chase, T N (1989) Memory impairment in patients with progressive supranuclear palsy Archives of Neurology, 46(7), 765–767 Litvan, I., Mega, M S., Cummings, J L., & Fairbanks, L (1996) Neuropsychiatric aspects of progressive supranuclear palsy Neurology, 47(5), 1184–1189 Liu, C., Cholerton, B., Shi, M., Ginghina, C., Cain, K C., Auinger, P.,  .  Zhang, J (2015) CSF tau and tau/Abeta predict cognitive decline in Parkinson’s disease Parkinsonism and Related Disorders doi: 10.1016/j.parkreldis.2014.12.027 Liu, Y., Li, W., Tan, C., Liu, X., Wang, X., Gui, Y.,  .  Chen, L (2014) Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease Journal of Neurosurgery, 121(3), 709–718 doi: 10.3171/2014.4.JNS131711 Loftus, A M., Bucks, R S., Thomas, M., Kane, R., Timms, C., Barker, R A., & Gasson, N (2015) Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson’s disease Journal of the International Neuropsychological Society , 21 (2), 137–145 doi: 10.1017/ S1355617715000041 Lombardi, W J., Woolston, D J., Roberts, J W., & Gross, R E (2001) Cognitive deficits in patients with essential tremor Neurology, 57(5), 785–790 Louis, E D., & Ferreira, J J (2010) How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor Movement Disorders, 25(5), 534–541 doi: 10.1002/mds.22838 Lyons, K E., & Tröster, A I (2015) Essential tremor In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp. 484– 500) New York: Oxford University Press MacDonald, A A., Seergobin, K N., Owen, A M., Tamjeedi, R., Monchi, O., Ganjavi, H., & MacDonald, P A (2013) Differential effects of Parkinson’s disease and dopamine replacement on memory encoding and retrieval PloS One, 8(9), e74044 doi: 10.1371/journal.pone.0074044 MacDonald, P A., MacDonald, A A., Seergobin, K N., Tamjeedi, R., Ganjavi, H., Provost, J S., & Monchi, O (2011) The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson’s disease: Support from functional MRI Brain, 134(Pt 5), 1447–1463 doi: 10.1093/brain/awr075 Maher, E R., Smith, E M., & Lees, A J (1985) Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy) Journal of Neurology, Neurosurgery, and Psychiatry, 48(12), 1234–1239 Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M J., Michelet, D., & Boller, F (1998) Neuropsychological prediction of dementia in Parkinson’s disease Journal of Neurology, Neurosurgery, and Psychiatry, 64(2), 178–183 Maier, F., Merkl, J., Ellereit, A L., Lewis, C J., Eggers, C., Pedrosa, D J.,  .  Timmermann, L (2014) Hypomania and mania related to dopamine replacement therapy in Parkinson’s disease Parkinsonism and Related Disorders, 20(4), 421–427 doi: 10.1016/j parkreldis.2014.01.001 Maier, F., Prigatano, G P., Kalbe, E., Barbe, M T., Eggers, C., Lewis, C J.,     Timmermann, L (2012) Impaired self-awareness of motor deficits in Parkinson’s disease: Association with motor asymmetry and motor phenotypes Movement Disorders, 27(11), 1443–1447 doi: 10.1002/mds.25079 Marder, K., Tang, M X., Cote, L., Stern, Y., & Mayeux, R (1995) The frequency and associated risk factors for dementia in patients with Parkinson’s disease Archives of Neurology, 52(7), 695–701 Marder, K., Zhao, H., Myers, R H., Cudkowicz, M., Kayson, E., Kieburtz, K.,  .  Shoulson, I (2000) Rate of functional decline in Huntington’s disease: Huntington study group Neurology, 54(2), 452–458 Marin, R S., Biedrzycki, R C., & Firinciogullari, S (1991) Reliability and validity of the apathy evaluation scale Psychiatry Research, 38(2), 143–162 Marras, C., Armstrong, M J., Meaney, C A., Fox, S., Rothberg, B., Reginold, W.,  .  Duff-Canning, S (2013) Measuring mild cognitive impairment in patients with Parkinson’s disease Movement Disorders, 28(5), 626–633 doi: 10.1002/mds.25426 Marsh, L., & Dobkin, R D (2015) Depression and anxiety in Parkinson’s disease In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp.  265–290) New York: Oxford University Press Marsh, L., McDonald, W M., Cummings, J., & Ravina, B (2006) Provisional diagnostic criteria for depression in Parkinson’s disease: Report of an NINDS/NIMH work group Movement Disorders, 21(2), 148–158 doi: 10.1002/mds.20723 Massman, P J., Delis, D C., Butters, N., Levin, B E., & Salmon, D P (1990) Are all subcortical dementias alike? Verbal learning and memory in Parkinson’s and Huntington’s disease patients Journal of Clinical and Experimental Neuropsychology, 12(5), 729–744 Massman, P J., Kreiter, K T., Jankovic, J., & Doody, R S (1996) Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer’s disease Neurology, 46(3), 720–726 Mata, I F., Leverenz, J B., Weintraub, D., Trojanowski, J Q., Hurtig, H I., Van Deerlin, V M.,  .  Zabetian, C P (2014) APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease JAMA Neurology, 71(11), 1405–1412 doi: 10.1001/ jamaneurol.2014.1455 Matison, R., Mayeux, R., Rosen, J., & Fahn, S (1982) “Tip-of-thetongue” phenomenon in Parkinson disease Neurology, 32(5), 567–570 Mayeux, R., Chen, J., Mirabello, E., Marder, K., Bell, K., Dooneief, G.,  .  Stern, Y (1990) An estimate of the incidence of dementia in idiopathic Parkinson’s disease Neurology, 40(10), 1513–1517 McDonald, W M., Richard, I H., & DeLong, M R (2003) Prevalence, etiology, and treatment of depression in Parkinson’s disease Biological Psychiatry, 54(3), 363–375 McDowd, J., Hoffman, L., Rozek, E., Lyons, K E., Pahwa, R., Burns, J., & Kemper, S (2011) Understanding verbal fluency in healthy aging, Alzheimer’s disease, and Parkinson’s disease Neuropsychology, 25(2), 210–225 doi: 10.1037/a0021531 McFie, J (1960) Psychological effects of stereotaxic operations for the relief of parkinsonian symptoms Journal of Mental Science, 106, 1512–1517 McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R.,  .  Spiegel, R (2000) Efficacy of rivastigmine in dementia 552 Alexander I Tröster and Robin Garrett with Lewy bodies: A randomised, double-blind, placebo-controlled international study Lancet, 356(9247), 2031–2036 McKinlay, A., Grace, R C., Dalrymple-Alford, J C., & Roger, D (2010) Characteristics of executive function impairment in Parkinson's disease patients without dementia Journal of the International Neuropsychological Society, 16, 268–277 doi: 10.1017/ S1355617709991299 McNamara, P., & Durso, R (2003) Pragmatic communication skills in patients with Parkinson’s disease Brain and Language, 84(3), 414–423 Meco, G., Casacchia, M., Lazzari, R., Franzese, A., Castellana, F., Carta, A.,  .  Agnoli, A (1984) Mental impairment in Parkinson’s disease: The role of anticholinergic drugs Acta Psychiatrica Belgique, 84(4), 325–335 Meco, G., Gasparini, M., & Doricchi, F (1996) Attentional functions in multiple system atrophy and Parkinson’s disease Journal of Neurology, Neurosurgery and Psychiatry, 60(4), 393–398 Menza, M., Dobkin, R D., Marin, H., Mark, M H., Gara, M., Buyske, S.,  .  Dicke, A (2009) A controlled trial of antidepressants in patients with Parkinson disease and depression Neurology, 72(10), 886–892 doi: 01.wnl.0000336340.89821.b3 [pii] 10.1212/01.wnl.0000336340.89821.b3 Merola, A., Rizzi, L., Artusi, C A., Zibetti, M., Rizzone, M G., Romagnolo, A.,  .  Lopiano, L (2014) Subthalamic deep brain stimulation: Clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients Journal of Neurology, 261(9), 1745–1751 doi: 10.1007/s00415-014-7414-8 Middleton, F A., & Strick, P L (2000) Basal ganglia output and cognition: Evidence from anatomical, behavioral, and clinical studies Brain and Cognition, 42(2), 183–200 Mimura, M., White, R F., & Albert, M L (1997) Corticobasal degeneration: Neuropsychological and clinical correlates Journal of Neuropsychiatry and Clinical Neurosciences, 9(1), 94–98 Mochizuki, A., Ueda, Y., Komatsuzaki, Y., Tsuchiya, K., Arai, T., & Shoji, S (2003) Progressive supranuclear palsy presenting with primary progressive aphasia-clinicopathological report of an autopsy case Acta Neuropathologica (Berlin), 105(6), 610–614 Mohlman, J., Chazin, D., & Georgescu, B (2011) Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson disease Journal of Geriatric Psychiatry and Neurology , 24 (2), 91–97 doi: 10.1177/0891988711402350 Mohr, E., Mendis, T., & Grimes, J D (1995) Late cognitive changes in Parkinson’s disease with an emphasis on dementia Advances in Neurology, 65, 97–113 Mondolo, F., Jahanshahi, M., Grana, A., Biasutti, E., Cacciatori, E., & Di Benedetto, P (2006) The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson’s disease Behavioural Neurology, 17(2), 109–115 Montgomery, S A., & Asberg, M (1979) A new depression scale designed to be sensitive to change British Journal of Psychiatry, 134, 382–389 Montine, T J., Shi, M., Quinn, J F., Peskind, E R., Craft, S., Ginghina, C.,  .  Zhang, J (2010) CSF Abeta(42) and tau in Parkinson’s disease with cognitive impairment Movement Disorders, 25(15), 2682–2685 doi: 10.1002/mds.23287 Montoya, A., Pelletier, M., Menear, M., Duplessis, E., Richer, F., & Lepage, M (2006) Episodic memory impairment in Huntington’s disease: A meta-analysis Neuropsychologia , 44 (10), 1984–1994 doi: S0028-3932(06)00027-3 [pii] 10.1016/j neuropsychologia.2006.01.015 Monza, D., Soliveri, P., Radice, D., Fetoni, V., Testa, D., Caffarra, P.,  .  Girotti, F (1998) Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes Archives of Neurology, 55(3), 372–378 Morgante, F., Edwards, M J., & Espay, A J (2013) Psychogenic movement disorders Continuum (Minneap Minn), 19(5 Movement Disorders), 1383–1396 doi: 10.1212/01.CON.0000436160 41071.79 Morley, J F., Xie, S X., Hurtig, H I., Stern, M B., Colcher, A., Horn, S.,  .  Siderowf, A (2012) Genetic influences on cognitive decline in Parkinson’s disease Movement Disorders, 27(4), 512– 518 doi: 10.1002/mds.24946 Morris, R G., Downes, J J., Sahakian, B J., Evenden, J L., Heald, A., & Robbins, T W (1988) Planning and spatial working memory in Parkinson’s disease Journal of Neurology, Neurosurgery, and Psychiatry, 51(6), 757–766 Mosley, P E., & Marsh, R (2015) The psychiatric and neuropsychiatric symptoms after subthalamic stimulation for Parkinson’s disease Journal of Neuropsychiatry and Clinical Neurosciences, 27(1), 19–26 doi: 10.1176/appi.neuropsych.14040069 Moustafa, A A., Bell, P., Eissa, A M., & Hewedi, D H (2013) The effects of clinical motor variables and medication dosage on working memory in Parkinson’s disease Brain and Cognition, 82(2), 137–145 doi: 10.1016/j.bandc.2013.04.001 Muenter, M D., Forno, L S., Hornykiewicz, O., Kish, S J., Maraganore, D M., Caselli, R J.,  .  Calne, D B (1998) Hereditary form of parkinsonism-dementia Brain and Cognition, 43(6), 768–781 doi: 10.1002/ana.410430612 Murphy, T., & Eddy, C M (2013) Neuropsychological assessment in Tourette syndrome In D Martino & J F Leckam (Eds.), Tourette Syndrome (pp. 439–484) New York: Oxford University Press Murray, L L (2000) Spoken language production in Huntington’s and Parkinson’s diseases Journal of Speech, Language, and Hearing Research, 43(6), 1350–1366 Muslimovic, D., Post, B., Speelman, J D., & Schmand, B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease Neurology, 65(8), 1239–1245 Myslobodsky, M., Lalonde, F M., & Hicks, L (2001) Are patients with Parkinson’s disease suicidal? Journal of Geriatric Psychiatry and Neurology, 14(3), 120–124 Naarding, P., Leentjens, A F., Van Kooten, F., & Verhey, F R (2002) Disease-specific properties of the Hamilton Rating Scale for depression in patients with stroke, Alzheimer’s dementia, and Parkinson’s disease Journal of Neuropsychiatry and Clinical Neurosciences, 14(3), 329–334 Nahan, F B., & Levin, B E (2011) Characterizing and assessing the spectrum of volition in psychogenic movement disorders In M Hallett, A E Lang, J Jankovic, S Fahn, P W Halligan, V Voon, & C R Cloninger (Eds.), Psychogenic Movement Disorders and Other Conversion Disorders (pp. 217–224) Cambridge, UK: Cambridge University Press Naismith, S L., Mowszowski, L., Diamond, K., & Lewis, S J (2013) Improving memory in Parkinson’s disease: A healthy brain ageing cognitive training program Movement Disorders, 28(8), 1097–1103 doi: 10.1002/mds.25457 Naismith, S L., Pereira, M., Shine, J M., & Lewis, S J (2011) How well caregivers detect mild cognitive change in Parkinson’s Parkinson’s and Other Movement Disorders 553 disease? Movement Disorders, 26(1), 161–164 doi: 10.1002/ mds.23331 Nath, U., Ben-Shlomo, Y., Thomson, R G., Morris, H R., Wood, N W., Lees, A J., & Burn, D J (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK Brain, 124(Pt 7), 1438–1449 Naville, F (1922) Les complications et let sequelles mentales de l’encephalite epidemique Encephale, 17, 369–375, 423–336 Noe, E., Marder, K., Bell, K L., Jacobs, D M., Manly, J J., & Stern, Y (2004) Comparison of dementia with Lewy bodies to Alzheimer’s disease and Parkinson’s disease with dementia Movement Disorders, 19(1), 60–67 Nombela, C., Bustillo, P J., Castell, P F., Sanchez, L., Medina, V., & Herrero, M T (2011) Cognitive rehabilitation in Parkinson’s disease: Evidence from neuroimaging Frontiers in Neurology, 2, 82 doi: 10.3389/fneur.2011.00082 Nuti, A., Ceravolo, R., Piccinni, A., Dell’Agnello, G., Bellini, G., Gambaccini, G.,  .  Bonuccelli, U (2004) Psychiatric comorbidity in a population of Parkinson’s disease patients European Journal of Neurology, 11(5), 315–320 doi: 10.1111/j.1468-1331.2004.00781.x O’Brien, J T., McKeith, I G., Walker, Z., Tatsch, K., Booij, J., Darcourt, J.,  .  Group, D.L.B S (2009) Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies British Journal of Psychiatry, 194(1), 34–39 doi: 10.1192/bjp bp.108.052050 Odekerken, V J., Boel, J A., Geurtsen, G J., Schmand, B A., Dekker, I P., de Haan, R J.,  .  Group, N S (2015) Neuropsychological outcome after deep brain stimulation for Parkinson disease Neurology , 84 (13), 1355–1361 doi: 10.1212/ WNL.0000000000001419 Odekerken, V J., van Laar, T., Staal, M J., Mosch, A., Hoffmann, C F., Nijssen, P C.,     de Bie, R M (2013) Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): A randomised controlled trial Lancet Neurology, 12(1), 37–44 doi: 10.1016/S1474-4422(12)70264-8 Okai, D., Askey-Jones, S., Samuel, M., O’Sullivan, S S., Chaudhuri, K R., Martin, A.,  .  David, A S (2013) Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers Neurology , 80 (9), 792–799 doi: 10.1212/ WNL.0b013e3182840678 Owen, A M., Doyon, J., Dagher, A., Sadikot, A., & Evans, A C (1998) Abnormal basal ganglia outflow in Parkinson’s disease identified with PET: Implications for higher cortical functions Brain, 121(Pt 5), 949–965 Owen, A M., Sahakian, B J., Hodges, J R., Summers, B A., Polkey, C E., & Robbins, T W (1995) Dopamine-dependent fronto-striatal planning deficits in early Parkinson’s disease Neuropsychology, 9, 126–140 Pagonabarraga, J., Kulisevsky, J., Strafella, A P., & Krack, P (2015) Apathy in Parkinson’s disease: Clinical features, neural substrates, diagnosis, and treatment Lancet Neurology, 14(5), 518–531 doi: 10.1016/S1474-4422(15)00019-8 Papoutsi, M., Labuschagne, I., Tabrizi, S J., & Stout, J C (2014) The cognitive burden in Huntington’s disease: Pathology, phenotype, and mechanisms of compensation Movement Disorders, 29(5), 673–683 doi: 10.1002/mds.25864 Paris, A P., Saleta, H G., de la Cruz Crespo Maraver, M., Silvestre, E., Freixa, M G., Torrellas, C P.,  .  Bayes, A R (2011) Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease Movement Disorders, 26(7), 1251–1258 doi: 10.1002/mds.23688 Park, I S., Oh, Y S., Lee, K S., Yang, D W., Song, I U., Park, J W., & Kim, J S (2015) Subtype of mild cognitive impairment in elderly patients with essential tremor Alzheimer Disease and Associated Disorders , 29 (2), 141–145 doi: 10.1097/ WAD.0000000000000054 Parkinson, J (1817) An Essay on the Shaking Palsy London: Sherwood, Neely & Jones Passafiume, D., Boller, F., & Keefe, M C (1986) Neuropsychological impairment in patients with Parkinson’s disease In I Grant & K M Adams (Eds.), Neuropsychological Assessment of Neuropsychiatric Disorders (pp. 374–383) New York: Oxford University Press Patel, N K., Heywood, P., O’Sullivan, K., McCarter, R., Love, S., & Gill, S S (2003) Unilateral subthalamotomy in the treatment of Parkinson’s disease Brain, 126(Pt 5), 1136–1145 Paulsen, J S (2011) Cognitive impairment in Huntington disease: Diagnosis and treatment Current Neurology and Neuroscience Reports, 11(5), 474–483 doi: 10.1007/s11910-011-0215-x Paulsen, J S., & Long, J D (2014) Onset of Huntington’s disease: Can it be purely cognitive? Movement Disorders, 29(11), 1342– 1350 doi: 10.1002/mds.25997 Pedersen, K F., Larsen, J P., Tysnes, O B., & Alves, G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: The Norwegian ParkWest study JAMA Neurology, 70(5), 580–586 doi: 10.1001/jamaneurol.2013.2110 Pena, J., Ibarretxe-Bilbao, N., Garcia-Gorostiaga, I., GomezBeldarrain, M A., Diez-Cirarda, M., & Ojeda, N (2014) Improving functional disability and cognition in Parkinson disease: Randomized controlled trial Neurology, 83(23), 2167– 2174 doi: 10.1212/WNL.0000000000001043 Perry, E K., Curtis, M., Dick, D J., Candy, J M., Atack, J R., Bloxham, C A.,  .  Perry, R H (1985) Cholinergic correlates of cognitive impairment in Parkinson’s disease: Comparisons with Alzheimer’s disease Journal of Neurology, Neurosurgery, and Psychiatry, 48(5), 413–421 Petersen, R C (2011) Clinical practice; Mild cognitive impairment The New England Journal of Medicine, 364(23), 2227–2234 doi: 10.1056/NEJMcp0910237 Pfeiffer, H C., Lokkegaard, A., Zoetmulder, M., Friberg, L., & Werdelin, L (2014) Cognitive impairment in early-stage nondemented Parkinson’s disease patients Acta Neurologica Scandinavica, 129(5), 307–318 doi: 10.1111/ane.12189 Pharr, V., Uttl, B., Stark, M., Litvan, I., Fantie, B., & Grafman, J (2001) Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy Neurology, 56(7), 957–963 Piatt, A L., Fields, J A., Paolo, A M., Koller, W C., & Tröster, A I (1999) Lexical, semantic, and action verbal fluency in Parkinson’s disease with and without dementia Journal of Clinical and Experimental Neuropsychology, 21(4), 435–443 Piccirilli, M., Piccinin, G L., D’Alessandro, P., Finali, G., Piccolini, C., Scarcella, M G., & Testa, A (1986) Cognitive performances in parkinsonians before and after bromocriptine therapy Acta Neurologica (Napoli), 8(3), 167–172 Pietracupa, S., Fasano, A., Fabbrini, G., Sarchioto, M., Bloise, M., Latorre, A.,     Berardelli, A (2013) Poor self-awareness of levodopa-induced dyskinesias in Parkinson’s disease: Clinical features and mechanisms Parkinsonism and Related Disorders, 19(11), 1004–1008 doi: 10.1016/j.parkreldis.2013.07.002 554 Alexander I Tröster and Robin Garrett Pillon, B., Blin, J., Vidailhet, M., Deweer, B., Sirigu, A., Dubois, B., & Agid, Y (1995) The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer’s disease Neurology, 45(8), 1477–1483 Pillon, B., Dubois, B., Lhermitte, F., & Agid, Y (1986) Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson’s disease, and Alzheimer’s disease Neurology, 36(9), 1179–1185 Pillon, B., Dubois, B., Ploska, A., & Agid, Y (1991) Severity and specificity of cognitive impairment in Alzheimer’s, Huntington’s, and Parkinson’s diseases and progressive supranuclear palsy Neurology, 41(5), 634–643 Pillon, B., Gouider-Khouja, N., Deweer, B., Vidailhet, M., Malapani, C., Dubois, B., & Agid, Y (1995) Neuropsychological pattern of striatonigral degeneration: Comparison with Parkinson’s disease and progressive supranuclear palsy Journal of Neurology, Neurosurgery, and Psychiatry, 58(2), 174–179 Pirozzolo, F J., Hansch, E C., Mortimer, J A., Webster, D D., & Kuskowski, M A (1982) Dementia in Parkinson disease: A neuropsychological analysis Brain and Cognition, 1(1), 71–83 Pirtosek, Z., Jahanshahi, M., Barrett, G., & Lees, A J (2001) Attention and cognition in bradykinetic-rigid syndromes: An event-related potential study Annals of Neurology, 50(5), 567–573 Poletti, M., Cavedini, P., & Bonuccelli, U (2011) Iowa gambling task in Parkinson’s disease Journal of Clinical and Experimental Neuropsychology, 33(4), 395–409 doi: 10.1080/13803395.2010.524150 Pondal, M., Del Ser, T., & Bermejo, F (1996) Anticholinergic therapy and dementia in patients with Parkinson’s disease Journal of Neurology, 243(7), 543–546 Pontone, G M., Williams, J R., Anderson, K E., Chase, G., Goldstein, S A., Grill, S.,  .  Marsh, L (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease Movement Disorders, 24(9), 1333–1338 doi: 10.1002/ mds.22611 Price, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I J., & Hotopf, M (2011) Antidepressants for the treatment of depression in neurological disorders: A systematic review and meta-analysis of randomised controlled trials Journal of Neurology, Neurosurgery and Psychiatry, 82(8), 914–923 doi: 10.1136/jnnp.2010.230862 Rajput, A H., Adler, C H., Shill, H A., & Rajput, A (2012) Essential tremor is not a neurodegenerative disease Neurodegenerative Disease Management, 2(3), 259–268 doi: 10.2217/ nmt.12.23 Ranchet, M., Paire-Ficout, L., Uc, E Y., Bonnard, A., Sornette, D., & Broussolle, E (2013) Impact of specific executive functions on driving performance in people with Parkinson’s disease Movement Disorders, 28, 1941–1948 doi: 10.1002/mds.25660 Raskin, S A., Woods, S P., Poquette, A J., McTaggart, A B., Sethna, J., Williams, R C., & Troster, A I (2010) A differential deficit in time-versus event-based prospective memory in Parkinson’s disease Neuropsychology, 25, 201–209 doi: 10.1037/a0020999 Ravina, B., Marder, K., Fernandez, H H., Friedman, J H., McDonald, W., Murphy, D.,  .  Goetz, C (2007) Diagnostic criteria for psychosis in Parkinson’s disease: Report of an NINDS, NIMH work group Movement Disorders, 22(8), 1061– 1068 doi: 10.1002/mds.21382 Reading, P J., Luce, A K., & McKeith, I G (2001) Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial Movement Disorders, 16(6), 1171–1174 Rebeiz, J J., Kolodny, E H., & Richardson, E P., Jr (1968) Corticodentatonigral degeneration with neuronal achromasia Archives of Neurology, 18(1), 20–33 Reid, W G., Broe, G A., Morris, J G., Hely, M A., Moss, N G., Genge, S A., Williamson P M (1992) The role of cholinergic deficiency in neuropsychological deficits in idiopathic Parkinson’s disease Dementia and Geriatric Cognitive Disorders, 3, 114–120 Reijnders, J S., Ehrt, U., Weber, W E., Aarsland, D., & Leentjens, A F (2008) A systematic review of prevalence studies of depression in Parkinson’s disease Movement Disorders, 23(2), 183–189; quiz 313 doi: 10.1002/mds.21803 Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D (2005) Depression in Parkinson’s disease: Loss of dopamine and noradrenaline innervation in the limbic system Brain, 128(Pt 6), 1314–1322 doi: 10.1093/brain/awh445 Respondek, G., Stamelou, M., Kurz, C., Ferguson, L W., Rajput, A., Chiu, W Z.,     Movement Disorder Society-endorsed, P.S.P.S.G (2014) The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases Movement Disorders, 29(14), 1758–1766 doi: 10.1002/ mds.26054 Reynolds, W M., & Kobak, K., A (1995) Hamilton Depression Inventory—A Self-Report Version of the Hamilton Depression Rating Scale (HDRS) Odessa, FL: Psychological Assessment Resources Richard, I H., Justus, A W., Greig, N H., Marshall, F., & Kurlan, R (2002) Worsening of motor function and mood in a patient with Parkinson’s disease after pharmacologic challenge with oral rivastigmine Clinical Neuropharmacology, 25(6), 296–299 Richard, I H., McDermott, M P., Kurlan, R., Lyness, J M., Como, P G., Pearson, N.,  .  Group, S.-P S (2012) A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease Neurology, 78(16), 1229–1236 doi: 10.1212/ WNL.0b013e3182516244 Rieger, M., Gauggel, S., & Burmeister, K (2003) Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions Neuropsychology, 17(2), 272–282 Riklan, M., & Levita, E (1969) Subcortical Correlates of Human Behavior: A Psychological Study of Thalamic and Basal Ganglia Surgery Baltimore: Williams & Wilkins Riley, D E., & Lang, A E (1996) Non-Parkinson akinetic-rigid syndromes Current Opinion in Neurology, 9(4), 321–326 Rinne, J O., Lee, M S., Thompson, P D., & Marsden, C D (1994) Corticobasal degeneration: A clinical study of 36 cases Brain, 117(Pt 5), 1183–1196 Rittman, T., Ghosh, B C., McColgan, P., Breen, D P., Evans, J., Williams-Gray, C H.,  .  Rowe, J B (2013) The Addenbrooke’s cognitive examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders Journal of Neurology, Neurosurgery and Psychiatry, 84(5), 544–551 doi: 10.1136/jnnp-2012-303618 Robbins, T W., James, M., Lange, K W., Owen, A M., Quinn, N P., & Marsden, C D (1992) Cognitive performance in multiple system atrophy Brain, 115(Pt 1), 271–291 Robbins, T W., James, M., Owen, A M., Lange, K W., Lees, A J., Leigh, P N.,  .  Summers, B A (1994) Cognitive deficits in progressive supranuclear palsy, Parkinson’s disease, and multiple Parkinson’s and Other Movement Disorders 555 system atrophy in tests sensitive to frontal lobe dysfunction Journal of Neurology, Neurosurgery, and Psychiatry, 57(1), 79–88 Robbins, T W., Owen, A M., & Sahakian, B J (1998) The neuropsychology of basal ganglia disorders: An integrative cognitive and comparative approach In M A Ron & A S David (Eds.), Disorders of Brain and Mind (pp. 57–83) Cambridge, UK: Cambridge University Press Rogers, R., & Wooley, C (2011) Diagnostic considerations for the assessment of malingering within the context of psychogenic movement disorders In M Hallett, A E Lang, J Jankovic, S Fahn, P W Halligan, V Voon, & C R Cloninger (Eds.), Psychogenic Movement Disorders and Other Conversion Disorders (pp. 240–247) Cambridge, UK: Cambridge University Press Rolinski, M., Fox, C., Maidment, I., & McShane, R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease Cochrane Database Systematic Reviews, 3, CD006504 doi: 10.1002/14651858.CD006504.pub2 Ross, C A., & Tabrizi, S J (2011) Huntington’s disease: From molecular pathogenesis to clinical treatment Lancet Neurology, 10(1), 83–98 doi: 10.1016/S1474-4422(10)70245-3 Ross, H F., Hughes, T A., Boyd, J L., Biggins, C A., Madeley, P., Mindham, R.H.S., & Spokes, E.G.S (1996) The evolution and profile of dementia in Parkinson’s disease In L Battistin, G Scarlato, T Caraceni, & S Ruggieri (Eds.), Advances in Neurology (Vol 69, pp. 343–347) Philadelphia, PA: Lippincott-Raven Publishers Rothlind, J C., York, M K., Carlson, K., Luo, P., Marks, W J., Jr., Weaver, F M.,  .  Group, C.S.P.S (2015) Neuropsychological changes following deep brain stimulation surgery for Parkinson’s disease: Comparisons of treatment at pallidal and subthalamic targets versus best medical therapy Journal of Neurology, Neurosurgery and Psychiatry , 86 (6), 622–629 doi: 10.1136/ jnnp-2014-308119 Sahgal, A., Galloway, P H., McKeith, I G., Lloyd, S., Cook, J H., Ferrier, I N., & Edwardson, J A (1992) Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types Archives of Neurology, 49(10), 1043–1046 Saint-Cyr, J A., Taylor, A E., & Lang, A E (1988) Procedural learning and neostriatal dysfunction in man Brain, 111(Pt 4), 941–959 Saint-Cyr, J A., Taylor, A E., & Lang, A E (1993) Neuropsychological and psychiatric side effects in the treatment of Parkinson’s disease Neurology, 43(Suppl 6)(12), S47–S52 Saint-Cyr, J A., & Trépanier, L L (2000) Neuropsychologic assessment of patients for movement disorder surgery Movement Disorders, 15(5), 771–783 Salmon, D P., & Galasko, D (1996) Neuropsychological aspects of Lewy body dementia In R Perry, I McKeith, & E Perry (Eds.), Dementia with Lewy Bodies: Clinical, Pathological, and Treatment Issues (pp. 99–113) Cambridge, UK: Cambridge University Press Salmon, D P., Galasko, D., Hansen, L A., Masliah, E., Butters, N., Thal, L J., & Katzman, R (1996) Neuropsychological deficits associated with diffuse Lewy body disease Brain and Cognition, 31(2), 148–165 Sammer, G., Reuter, I., Hullmann, K., Kaps, M., & Vaitl, D (2006) Training of executive functions in Parkinson’s disease Journal of the Neurological Sciences, 248(1–2), 115–119 doi: S0022510X(06)00224-3 [pii] 10.1016/j.jns.2006.05.028 Schiffer, R B., Kurlan, R., Rubin, A., & Boer, S (1988) Evidence for atypical depression in Parkinson’s disease American Journal of Psychiatry, 145(8), 1020–1022 Schiller, F (2000) Fritz Lewy and his bodies Journal of the History of the Neurosciences, 9, 148–151 Schmahmann, J D (2001) The cerebrocerebellar system: Anatomic substrates of the cerebellar contribution to cognition and emotion International Review of Psychiatry, 13, 247–260 Schmahmann, J D., & Sherman, J C (1998) The cerebellar cognitive affective syndrome Brain, 121(Pt 4), 561–579 Schmand, B., & Tröster, A I (2015) Earliest cognitive changes and mild cognitive impairment in Parkinson’s disease In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp. 205–238) New York: Oxford University Press Schrag, A., Barone, P., Brown, R G., Leentjens, A F., McDonald, W M., Starkstein, S.,  .  Goetz, C G (2007) Depression rating scales in Parkinson’s disease: Critique and recommendations Movement Disorders, 22(8), 1077–1092 Schrag, A., Ben-Shlomo, Y., & Quinn, N P (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study Lancet, 354(9192), 1771–1775 Scott, R B., Gregory, R., Wilson, J., Banks, S., Turner, A., Parkin, S.,  .  Aziz, T (2003) Executive cognitive deficits in primary dystonia Movement Disorders, 18(5), 539–550 Seichepine, D R., Neargarder, S., Davidsdottir, S., Reynolds, G O., & Cronin-Golomb, A (2015) Side and type of initial motor symptom influences visuospatial functioning in Parkinson’s disease Journal of Parkinsons Disease, 5(1), 75–83 doi: 10.3233/ JPD-140365 Seltzer, B., Vasterling, J J., Mathias, C W., & Brennan, A (2001) Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: A comparative study Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 14(2), 122–129 Shapiro, D Y., Sadowsky, D A., Henderson, W G., & Van Buren, J M (1973) An assessment of cognitive function in postthalamotomy Parkinson patients Confinia Neurologica, 35(3), 144–166 Sharp, M E., & Alcalay, R N (2015) Genetics and cognition in Parkinson’s disease In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp. 179–204) New York: Oxford University Press Shaskin, D., Yarnell, H., & Alper, K (1942) Physical, psychiatric, and psychometric studies of post-encephalitic parkinsonism Journal of Nervous and Mental Disease, 96, 652–662 Sheikh, J I., & Yesavage, J A (1986) Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version Clinical Gerontologist, 5, 165–173 Shimomura, T., Mori, E., Yamashita, H., Imamura, T., Hirono, N., Hashimoto, M.,     Hanihara, T (1998) Cognitive loss in dementia with Lewy bodies and Alzheimer disease Archives of Neurology, 55(12), 1547–1552 Shulman, L M., Taback, R L., Rabinstein, A A., & Weiner, W J (2002) Non-recognition of depression and other non-motor symptoms in Parkinson’s disease Parkinsonism and Related Disorders, 8, 193–197 Siegert, R J., Weatherall, M., Taylor, K D., & Abernethy, D A (2008) A meta-analysis of performance on simple span and more 556 Alexander I Tröster and Robin Garrett complex working memory tasks in Parkinson’s disease Neuropsychology, 22(4), 450–461 doi: 10.1037/0894-4105.22.4.450 Siegfried, J., & Blond, S (1997) The Neurosurgical Treatment of Parkinson’s Disease and Other Movement Disorders London: Williams & Wilkins Europe Ltd Siepel, F J., Bronnick, K S., Booij, J., Ravina, B M., Lebedev, A V., Pereira, J B.,  .  Aarsland, D (2014) Cognitive executive impairment and dopaminergic deficits in de novo Parkinson’s disease Movement Disorders, 29(14), 1802–1808 doi: 10.1002/ mds.26051 Sinforiani, E., Banchieri, L., Zucchella, C., Pacchetti, C., & Sandrini, G (2004) Cognitive rehabilitation in Parkinson’s disease Archives of Gerontology and Geriatrics Supplements (9), 387–391 Sitek, E J., Soltan, W., Wieczorek, D., Robowski, P., & Slawek, J (2011) Self-awareness of memory function in Parkinson’s disease in relation to mood and symptom severity Aging and Mental Health, 15(2), 150–156 doi: 10.1080/13607863.2010.508773 Slaughter, J R., Slaughter, K A., Nichols, D., Holmes, S E., & Martens, M P (2001) Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson’s disease Journal of Neuropsychiatry and Clinical Neurosciences, 13(2), 187–196 Smeding, H M., Speelman, J D., Huizenga, H M., Schuurman, P R., & Schmand, B (2011) Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s Disease Journal of Neurology, Neurosurgery, and Psychiatry, 82(7), 754–760 doi: 10.1136/jnnp.2007.140012 Soliveri, P., Monza, D., Paridi, D., Carella, F., Genitrini, S., Testa, D., & Girotti, F (2000) Neuropsychological follow up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy Journal of Neurology, Neurosurgery, and Psychiatry, 69(3), 313–318 Soliveri, P., Monza, D., Paridi, D., Radice, D., Grisoli, M., Testa, D.,     Girotti, F (1999) Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy Neurology, 53(3), 502–507 Souchay, C., & Smith, S J (2013) Autobiographical memory in Parkinson’s disease: A retrieval deficit Journal of Neuropsychology, 7(2), 164–178 doi: 10.1111/jnp.12014 Stankovic, I., Krismer, F., Jesic, A., Antonini, A., Benke, T., Brown, R G.,  .  Movement Disorders Society, M.S.A.S.G (2014) Cognitive impairment in multiple system atrophy: A position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group Movement Disorders, 29(7), 857–867 doi: 10.1002/mds.25880 Starkstein, S E., Bolduc, P L., Mayberg, H S., Preziosi, T J., & Robinson, R G (1990) Cognitive impairments and depression in Parkinson’s disease: A follow up study Journal of Neurology, Neurosurgery, and Psychiatry, 53(7), 597–602 Starkstein, S E., Mayberg, H S., Preziosi, T J., Andrezejewski, P., Leiguarda, R., & Robinson, R G (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease Journal of Neuropsychiatry and Clinical Neurosciences, 4(2), 134–139 Starkstein, S E., Merello, M., Jorge, R., Brockman, S., Bruce, D., Petracca, G., & Robinson, R G (2008) A validation study of depressive syndromes in Parkinson’s disease Movement Disorders, 23(4), 538–546 doi: 10.1002/mds.21866 Stebbins, G T., Gabrieli, J D., Masciari, F., Monti, L., & Goetz, C G (1999) Delayed recognition memory in Parkinson’s disease: A role for working memory? Neuropsychologia, 37(4), 503–510 Stefanova, E D., Kostic, V S., Ziropadja, L J., Ocic, G G., & Markovic, M (2001) Declarative memory in early Parkinson’s disease: Serial position learning effects Journal of Clinical and Experimental Neuropsychology, 23(5), 581–591 Stein, M B., Heuser, I J., Juncos, J L., & Uhde, T W (1990) Anxiety disorders in patients with Parkinson’s disease American Journal of Psychiatry, 147(2), 217–220 Stern, Y., Mayeux, R., Ilson, J., Fahn, S., & Cote, L (1984) Pergolide therapy for Parkinson’s disease: Neurobehavioral changes Neurology, 34(2), 201–204 Stern, Y., Mayeux, R., & Rosen, J (1984) Contribution of perceptual motor dysfunction to construction and tracing disturbances in Parkinson’s disease Journal of Neurology, Neurosurgery, and Psychiatry, 47(9), 983–989 Stern, Y., Tang, M X., Jacobs, D M., Sano, M., Marder, K., Bell, K.,  .  Côté, L (1998) Prospective comparative study of the evolution of probable Alzheimer’s disease and Parkinson’s disease dementia Journal of the International Neuropsychological Society, 4(3), 279–284 Stout, J C., Paulsen, J S., Queller, S., Solomon, A C., Whitlock, K B., Campbell, J C.,  .  Aylward, E H (2011) Neurocognitive signs in prodromal Huntington disease Neuropsychology, 25(1), 1–14 doi: 10.1037/a0020937 Sullivan, E V., & Sagar, H J (1989) Nonverbal recognition and recency discrimination deficits in Parkinson’s disease and Alzheimer’s disease Brain, 112(Pt 6), 1503–1517 Tabrizi, S J., Reilmann, R., Roos, R A., Durr, A., Leavitt, B., Owen, G.,  .  Investigators, T.-H (2012) Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACKHD study: Analysis of 24 month observational data Lancet Neurology, 11(1), 42–53 doi: 10.1016/S1474-4422(11)70263-0 Tabrizi, S J., Scahill, R I., Owen, G., Durr, A., Leavitt, B R., Roos, R A.,  .  Investigators, T.-H (2013) Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: Analysis of 36-month observational data Lancet Neurology, 12(7), 637–649 doi: 10.1016/S1474-4422(13)70088-7 Taylor, A E., & Saint-Cyr, J A (1995) The neuropsychology of Parkinson’s disease Brain and Cognition, 28(3), 281–296 Taylor, A E., Saint-Cyr, J A., & Lang, A E (1986) Frontal lobe dysfunction in Parkinson’s disease: The cortical focus of neostriatal outflow Brain, 109(Pt 5), 845–883 Testa, D., Fetoni, V., Soliveri, P., Musicco, M., Palazzini, E., & Girotti, F (1993) Cognitive and motor performance in multiple system atrophy and Parkinson’s disease compared Neuropsychologia, 31(2), 207–210 Thaler, A., Mirelman, A., Gurevich, T., Simon, E., Orr-Urtreger, A., Marder, K.,  .  Giladi, N (2012) Lower cognitive performance in healthy G2019S LRRK2 mutation carriers Neurology, 79(10), 1027–1032 doi: 10.1212/WNL.0b013e3182684646 Tierney, M C., Nores, A., Snow, W G., Fisher, R H., Zorzitto, M L., & Reid, D W (1994) Use of the Rey Auditory Verbal Learning Test in differentiating normal aging from Alzheimer’s and Parkinson’s dementia Psychological Assessment, 6(2), 129–134 Tomer, R., & Levin, B E (1993) Differential effects of aging on two verbal fluency tasks Perceptual and Motor Skills, 76(2), 465–466 Torkamani, M., & Jahanshahi, M (2015) Neuropsychological and neuropsychiatric features of dystonia and the impact of medical and surgical treatment In A I Tröster (Ed.), Clinical Parkinson’s and Other Movement Disorders 557 Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp. 455–483) New York: Oxford University Press Tröster, A I (2011) A precis of recent advances in the neuropsychology of mild cognitive impairment(s) in Parkinson’s disease and a proposal of preliminary research criteria Journal of the International Neuropsychological Society, 17, 393–406 doi: 10.1017/S1355617711000257 Tröster, A I., & Browner, N (2013) Movement disorders with dementia in older adults In L D Ravdin & H L Katzen (Eds.), Handbook on the Neuropsychology of Aging and Dementia (pp. 333–361) New York: Springer Tröster, A I., & Fields, J A (1995) Frontal cognitive function and memory in Parkinson’s disease: Toward a distinction between prospective and declarative memory impairments? Behavioural Neurology, 8, 59–74 Tröster, A I., & Fields, J A (2003) The role of neuropsychological evaluation in the neurosurgical treatment of movement disorders In D Tarsy, J L Vitek, & A M Lozano (Eds.), Surgical Treatment of Parkinson’s Disease and Other Movement Disorders (pp. 213–240) Totowa, NJ: Humana Press Tröster, A I., Fields, J A., Testa, J A., Paul, R H., Blanco, C R., Hames, K A.,  .  Beatty, W W (1998) Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks Neuropsychologia, 36(4), 295–304 Troster, A I., Pahwa, R., Fields, J A., Tanner, C M., & Lyons, K E (2005) Quality of life in Essential Tremor Questionnaire (QUEST): Development and initial validation Parkinsonism Relat Disord, 11(6), 367–373 Troster, A I., Paolo, A M., Lyons, K E., Glatt, S L., Hubble, J P., & Koller, W C (1995) The influence of depression on cognition in Parkinson’s disease: A pattern of impairment distinguishable from Alzheimer’s disease Neurology, 45(4), 672–676 Tröster, A I., Prizer, L P., & Baxley, A (2013) Parkinson’s disease: Secondary influences on cognition In P A Arnett (Ed.), Secondary Influences on Neuropsychological Test Performance (pp. 259– 291) New York: Oxford University Press Tröster, A I., Stalp, L D., Paolo, A M., Fields, J A., & Koller, W C (1995) Neuropsychological impairment in Parkinson’s disease with and without depression Archives of Neurology, 52(12), 1164–1169 Tröster, A I., & Tucker, K A (2005) Impact of essential tremor and its medical and surgical treatment on neuropsychological functioning, activities of daily living, and quality of life In K E Lyons & R Pahwa (Eds.), Handbook of Essential Tremor and Other Tremor Disorders (pp. 117–131) Boca Raton, FL: Taylor and Francis Tröster, A I., & Woods, S P (2003) Neuropsychological aspects of Parkinson’s disease and parkinsonian syndromes In R Pahwa, K E Lyons, & W C Koller (Eds.), Handbook of Parkinson’s Disease (3rd ed., pp. 127–157) New York: Marcel Dekker Tröster, A I., Woods, S P., Fields, J A., Lyons, K E., Pahwa, R., Higginson, C I., & Koller, W C (2002) Neuropsychological deficits in essential tremor: An expression of cerebello-thalamocortical pathophysiology? European Journal of Neurology, 9(2), 143–151 Troyer, A K., Moscovitch, M., Winocur, G., Leach, L., & Freedman, M (1998) Clustering and switching on verbal fluency tests in Alzheimer’s and Parkinson’s disease Journal of the International Neuropsychological Society, 4(2), 137–143 Ullman, M T., Corkin, S., Coppola, M., Hickok, G., Growdon, J H., Koroshetz, W J., & Pinker, S (1997) A neural dissociation within language: Evidence that the mental dictionary is part of declarative memory, and that grammatical rules are processed by the procedural system Journal of Cognitive Neuroscience, 9, 266–276 van der Hurk, P R., & Hodges, J R (1995) Episodic and semantic memory in Alzheimer’s disease and progressive supranuclear palsy: A comparative study Journal of Clinical and Experimental Neuropsychology, 17(3), 459–471 van Duijn, E., Kingma, E M., & van der Mast, R C (2007) Psychopathology in verified Huntington’s disease gene carriers Journal of Neuropsychiatry and Clinical Neurosciences, 19(4), 441–448 doi: 19/4/441 [pii] 10.1176/appi.neuropsych.19.4.441 van Oostrom, I., Dollfus, S., Brazo, P., Abadie, P., Halbecq, I., Théry, S., & Marié, R.-M (2003) Verbal learning and memory in schizophrenic and Parkinson’s disease patients Psychiatry Research, 117, 25–34 Varanese, S., Perfetti, B., Monaco, D., Thomas, A., Bonanni, L., Tiraboschi, P., & Onofrj, M (2010) Fluctuating cognition and different cognitive and behavioural profiles in Parkinson’s disease with dementia: Comparison of dementia with Lewy bodies and Alzheimer’s disease Journal of Neurology, 257(6), 1004–1011 doi: 10.1007/s00415-010-5453-3 Vazquez, A., Jimenez-Jimenez, F J., Garcia-Ruiz, P., & GarciaUrra, D (1993) “Panic attacks” in Parkinson’s disease: A longterm complication of levodopa therapy Acta Neurologica Scandanavica, 87(1), 14–18 Veazey, C., Cook, K F., Stanley, M., Lai, E C., & Kunik, M E (2009) Telephone-administered cognitive behavioral therapy: A case study of anxiety and depression in Parkinson’s disease Journal of Clinical Psychology in Medical Settings, 16(3), 243–253 doi: 10.1007/s10880-009-9167-6 Venneri, A., Nichelli, P., Modonesi, G., Molinari, M A., Russo, R., & Sardini, C (1997) Impairment in dating and retrieving remote events in patients with early Parkinson’s disease Journal of Neurology, Neurosurgery, and Psychiatry, 62(4), 410–413 Vilkki, J., & Laitinen, L V (1974) Differential effects of left and right ventrolateral thalamotomy on receptive and expressive verbal performances and face-matching Neuropsychologia, 12(1), 11–19 Volkmann, J., Daniels, C., & Witt, K (2010) Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease Nature Reviews Neurology , (9), 487–498 doi: 10.1038/ nrneurol.2010.111 Voon, V (2015) Impulse control disorders In H Reichmann (Ed.), Neuropsychiatric Symptoms of Movement Disorders (pp. 79–98) Cham, Switzerland: Springer Voon, V., & Lang, A E (2005) Antidepressant treatment outcomes of psychogenic movement disorder Journal of Clinical Psychiatry, 66(12), 1529–1534 Walker, M P., Ayre, G A., Perry, E K., Wesnes, K., McKeith, I G., Tovee, M.,  .  Ballard, C G (2000) Quantification and characterisation of fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease Dementia and Geriatric Cognitive Disorders, 11(6), 327–335 Walker, Z., Allen, R L., Shergill, S., & Katona, C L (1997) Neuropsychological performance in Lewy body dementia and Alzheimer’s disease British Journal of Psychiatry, 170, 156–158 Walsh, K., & Bennett, G (2001) Parkinson’s disease and anxiety Postgraduate Medical Journal, 77(904), 89–93 558 Alexander I Tröster and Robin Garrett Wang, H F., Yu, J T., Tang, S W., Jiang, T., Tan, C C., Meng, X F.,  .  Tan, L (2015) Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson’s disease, Parkinson’s disease dementia, and dementia with Lewy bodies: Systematic review with meta-analysis and trial sequential analysis Journal of Neurology Neurosurgery and Psychiatry, 86(2), 135–143 doi: 10.1136/jnnp-2014-307659 Weddell, R A., & Weiser, R (1995) A double-blind cross-over placebo-controlled trial of the effects of bromocriptine on psychomotor function, cognition, and mood in de novo patients with Parkinson’s disease Behavioural Pharmacology, 6, 81–91 Weintraub, D., David, A S., Evans, A H., Grant, J E., & Stacy, M (2015) Clinical spectrum of impulse control disorders in Parkinson’s disease Movement Disorders, 30(2), 121–127 doi: 10.1002/ mds.26016 Weintraub, D., & Goldman, J G (2015) Impulse control disorders, apathy, and psychosis In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp.  291–331) New York: Oxford University Press Weintraub, D., Hoops, S., Shea, J A., Lyons, K E., Pahwa, R., Driver-Dunckley, E D.,  .  Voon, V (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease Movement Disorders, 24, 1461–1467 doi: 10.1002/ mds.22571 Weintraub, D., Koester, J., Potenza, M N., Siderowf, A D., Stacy, M., Voon, V.,  .  Lang, A E (2010) Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients Archives of Neurology , 67 (5), 589–595 doi: 10.1001/ archneurol.2010.65 Weintraub, D., Mamikonyan, E., Papay, K., Shea, J A., Xie, S X., & Siderowf, A (2012) Questionnaire for impulsive-compulsive disorders in Parkinson’s disease-rating scale Movement Disorders, 27(2), 242–247 doi: 10.1002/mds.24023 Weintraub, D., Moberg, P J., Culbertson, W C., Duda, J E., Katz, I R., & Stern, M B (2005) Dimensions of executive function in Parkinson’s disease Dementia and Geriatric Cognitive Disorders, 20, 140–144 Weintraub, D., Moberg, P J., Duda, J E., Katz, I R., & Stern, M B (2003) Recognition and treatment of depression in Parkinson’s disease Journal of Geriatric Psychiatry and Neurology, 16(3), 178–183 Weintraub, D., Oehlberg, K A., Katz, I R., & Stern, M B (2006) Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease American Journal of Geriatric Psychiatry, 14(2), 169–175 Weintraub, D., Siderowf, A D., Tröster, A I., & Anderson, K E (2011) Parkinson’s disease and movement disorders In C E Coffey, J L Cummings, M S George, & D Weintraub (Eds.), Textbook of Geriatric Neuropsychiatry (3rd ed., pp.  569–597) Washington, DC: American Psychiatric Press Weintraub, D., Simuni, T., Caspell-Garcia, C., Coffey, C., Lasch, S., Siderowf, A.,  .  The Parkinson’s Progression Markers, I (2015) Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson’s disease Movement Disorders, 30, 919–927 doi: 10.1002/mds.26170 Welman, A J (1971) Neuropsychologische Untersuchung von Parkinsonpatienten (Vor und nach Thalomotomie) Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie, 108(1), 175–188 Wenning, G K., Colosimo, C., Geser, F., & Poewe, W (2004) Multiple system atrophy Lancet Neurology, 3, 93–103 Wenning, G K., Seppi, K., Scherfler, C., Stefanova, N., & Puschban, Z (2001) Multiple system atrophy Seminars in Neurology, 21(1), 33–40 Whittington, C J., Podd, J., & Kan, M M (2000) Recognition memory impairment in Parkinson’s disease: Power and metaanalyses Neuropsychology, 14(2), 233–246 Wichmann, T., & De Long, M R (2015) Basal ganglia circuits: Structure, function and dysfunction In A I Tröster (Ed.), Clinical Neuropsychology and Cognitive Neurology of Parkinson’s Disease and Other Movement Disorders (pp.  3–26) New York: Oxford University Press Williams, D R., de Silva, R., Paviour, D C., Pittman, A., Watt, H C., Kilford, L.,     Lees, A J (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism Brain, 128(Pt 6), 1247–1258 Williams, J R., Hirsch, E S., Anderson, K., Bush, A L., Goldstein, S R., Grill, S.,  .  Marsh, L (2012) A comparison of nine scales to detect depression in Parkinson disease: Which scale to use? N e u ro l o gy , 78(13), 998–1006 doi: 10.1212/ WNL.0b013e31824d587f Williams, N R., Foote, K D., & Okun, M S (2014) STN vs GPi Deep brain stimulation: Translating the rematch into clinical practice Movement Disorders: Clinical Practice, 1(1), 24–35 doi: 10.1002/mdc3.12004 Williams-Gray, C H., Evans, J R., Goris, A., Foltynie, T., Ban, M., Robbins, T W.,  .  Barker, R A (2009) The distinct cognitive syndromes of Parkinson’s disease: year follow-up of the CamPaIGN cohort Brain, 132(Pt 11), 2958–2969 doi: awp245 [pii] 10.1093/brain/awp245 Williams-Gray, C H., Goris, A., Saiki, M., Foltynie, T., Compston, D A., Sawcer, S J., & Barker, R A (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s disease Journal of Neurology, 256(3), 493–498 doi: 10.1007/s00415-009-0119-8 Williams-Gray, C H., Hampshire, A., Barker, R A., & Owen, A M (2008) Attentional control in Parkinson’s disease is dependent on COMT val 158 met genotype Brain, 131(Pt 2), 397–408 doi: awm313 [pii] 10.1093/brain/awm313 Williams-Gray, C H., Mason, S L., Evans, J R., Foltynie, T., Brayne, C., Robbins, T W., & Barker, R A (2013) The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort Journal of Neurology, Neurosurgery and Psychiatry, 84(11), 1258–1264 doi: 10.1136/ jnnp-2013-305277 Winterer, G., & Goldman, D (2003) Genetics of human prefrontal function Brain Research Brain Research Reviews, 43(1), 134–163 Wirdefeldt, K., Adami, H O., Cole, P., Trichopoulos, D., & Mandel, J (2011) Epidemiology and etiology of Parkinson’s disease: A review of the evidence European Journal of Epidemiology, 26(Suppl 1), S1–S58 doi: 10.1007/s10654-011-9581-6 Wolf, R C., Sambataro, F., Vasic, N., Baldas, E M., Ratheiser, I., Bernhard Landwehrmeyer, G.,  .  Orth, M (2014) Visual system integrity and cognition in early Huntington’s disease European Journal of Neuroscience, 40(2), 2417–2426 doi: 10.1111/ ejn.12575 Woods, S P., Fields, J A., Lyons, K E., Koller, W C., Wilkinson, S B., Pahwa, R., & Tröster, A I (2001) Neuropsychological and Parkinson’s and Other Movement Disorders 559 quality of life changes following unilateral thalamic deep brain stimulation in Parkinson’s disease: A 12-month follow-up Acta Neurochirurgica, 143, 1273–1278 Woods, S P., Scott, J C., Fields, J A., Poquette, A., & Troster, A I (2008) Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremor Cognitive and Behavioral Neurology, 21(1), 28–33 Woods, S P., & Tröster, A I (2003) Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease Journal of the International Neuropsychological Society, 9, 17–24 Woodward, T S., Bub, D N., & Hunter, M A (2002) Task switching deficits associated with Parkinson’s disease reflect depleted attentional resources Neuropsychologia, 40(12), 1948–1955 Wszolek, Z K., Tsuboi, Y., Uitti, R J., Reed, L., Hutton, M L., & Dickson, D W (2001) Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation Brain, 124(Pt 8), 1666–1670 Xuereb, J H., Tomlinson, B E., Irving, D., Perry, R H., Blessed, G., & Perry, E K (1990) Cortical and subcortical pathology in Parkinson’s disease: Relationship to parkinsonian dementia Advances in Neurology, 53, 35–40 Yesavage, J., Brink, T L., Rose, T L., Lum, O., Huang, V., Adey, M., & Leirer, V O (1983) Development and validation of a geriatric depression screening scale Journal of Psychiatric Research, 17, 37–49 Zec, R F., Landreth, E S., Fritz, S., Grames, E., Hasara, A., Fraizer, W.,  .  Manyam, B (1999) A comparison of phonemic, semantic, and alternating word fluency in Parkinson’s disease Archives of Clinical Neuropsychology, 14(3), 255–264 Zeuner, K E., & Deuschl, G (2012) An update on tremors Current Opinion in Neurology, 25(4), 475–482 doi: 10.1097/ WCO.0b013e3283550c7e Zgaljardic, D J., Borod, J C., Foldi, N S., & Mattis, P (2003) A review of the cognitive and behavioral sequelae of Parkinson’s disease: Relationship to frontostriatal circuitry Cognitive and Behavioral Neurology, 16(4), 193–210 Zigmond, A S., & Snaith, R P (1983) The hospital anxiety and depression scale Acta Psychiatrica Scandinavica , 67 (6), 361–370 Zimmermann, R., Gschwandtner, U., Benz, N., Hatz, F., Schindler, C., Taub, E., & Fuhr, P (2014) Cognitive training in Parkinson disease: Cognition-specific vs nonspecific computer training Neurology, 82(14), 1219–1226 doi: 10.1212/WNL.0000000000000287 ... through their capacity to measure various aspects of Table 1. 2 10 11 12 13 14 15 16 17 18 19 20 21 Halstead’s quantitative indicators (Halstead, 19 47) Carl-Hollow Squares Test Halstead Category... collaboration of Heinrich Kluver (18 97 19 79) and Paul Bucy (19 04 19 93) and their famous observations on the Table 1. 1 (19 19) Battery of mental tests used by Shepard Ivory Franz Tests of Sensation Tests of. .. andrew zabel 11 Traumatic Brain Injury in Children and Adolescents keith owen yeates and brian l brooks 11 1 12 5 12 7 14 1 12 Pediatric Cancer celiane rey-casserly and brenda j spiegler 15 8 13 Autism
- Xem thêm -

Xem thêm: Ebook Textbook of clinical neuropsychology (2/E): Part 1, Ebook Textbook of clinical neuropsychology (2/E): Part 1

Tài liệu mới đăng

Gợi ý tài liệu liên quan cho bạn